Page last updated: 2024-08-24

ziprasidone and Dementia Praecox

ziprasidone has been researched along with Dementia Praecox in 356 studies

Research

Studies (356)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	8 (2.25)	18.2507
2000's	206 (57.87)	29.6817
2010's	128 (35.96)	24.3611
2020's	14 (3.93)	2.80

Authors

Authors	Studies
Bristow, LJ; Hutson, PH; Rowley, M	1
Shahid, M; Walker, GB; Wong, EH; Zorn, SH	1
Bali, A; Dhir, H; Kumar, A; Malhotra, S; Sharma, A	1
Guan, X; Kosten, TR; Liu, J; Wang, Y; Wu, F; Xiu, M; Zhang, X; Zhu, C	1
Chen, Q; Deng, W; Du, X; Hao, Q; Hu, X; Li, C; Li, K; Li, L; Li, T; Li, X; Lu, T; Lv, L; Ma, X; Ren, H; Tan, L; Tan, Q; Tang, Y; Wang, C; Wang, L; Wang, Q; Wang, Y; Wu, Y; Yan, H; Yang, F; Yang, G; Yang, J; Yu, H; Yue, W; Zhang, D; Zhang, F; Zhang, G; Zhang, H; Zhang, Y; Zhao, L	1
Bai, L; Guo, Y; Li, J; Li, K; Li, Y; Liang, W; Liu, L; Liu, Z; Wang, J; Wang, X; Wu, Y; Xu, J; Yang, F; Yu, J; Zhang, C; Zhang, Y	1
Cañete, T; Fernández-Teruel, A; Lavín, V; Oliveras, I; Río-Álamos, C; Sampedro-Viana, D; Sánchez-González, A; Sanna, F; Tapias-Espinosa, C; Tobeña, A; Torrecilla, P	1
Crippa, A; Davis, JM; Leucht, S; Orsini, N; Patel, MX; Siafis, S	1
Broder, MS; Chang, E; Greene, M; Houle, CR; Tarbox, MH; Waters, HC; Yan, T	1
Ayesa-Arriola, R; Crespo-Facorro, B; Gómez-Revuelta, M; Juncal-Ruiz, M; Pelayo-Terán, JM; Romero-Jiménez, R; Setién Suero, E; Suárez-Pinilla, P; Vázquez-Bourgon, J	1
Madden, K; Mahgoub, Y; Xia, T	1
Correll, CU; DiPetrillo, L; Jiang, Y; Liu, Y; Pathak, S; Todtenkopf, MS	1
Chen, Q; Coid, J; Deng, W; Guo, W; Hu, X; Li, K; Li, L; Li, T; Li, X; Li, Y; Lu, T; Lv, L; Ma, X; Ren, H; Reynolds, GP; Tan, L; Tan, Q; Tian, Y; Wang, C; Wang, H; Wang, L; Wang, Q; Wei, W; Yan, H; Yang, F; Yang, G; Yang, J; Yu, H; Yue, W; Zhang, D; Zhang, F; Zhang, H; Zhang, Y; Zhao, L	1
Buchmann, J; Dück, A; Grözinger, M; Häßler, F; Hofmockel, R; Höppner, J; Reinhardt, M; Weirich, S	1
Ahmad, FJ; Ahmed, MZ; Hasan, N; Jain, GK; Khan, UA; Parveen, U; Saad, S	1
Claro, A; Corte-Real, F; Franco, J; Monteiro, C; Mustra, C; Proença, P	1
Ayesa Arriola, R; Crespo Facorro, B; Gómez Revuelta, M; Ibáñez Alario, M; Juncal Ruiz, M; Mayoral-van Son, J; Ortiz-García de la Foz, V; Vázquez-Bourgon, J	1
Crespo-Facorro, B; Gomez-Arnau, J; Juncal-Ruiz, M; Martinez-Garcia, O; Neergaard, KD; Ortiz-Garcia de la Foz, V; Ramirez-Bonilla, M; Suarez-Pinilla, P; Tabares-Seisdedos, R	1
Cao, D; Kang, B; Meng, Y; Ning, H; Wang, H; Xie, S	1
Kou, C; Liu, X; Liu, Y; Ma, Y; Song, Y; Su, Y; Wang, M; Yang, G; You, Y; Zhang, L; Zhang, Y	1
Siegfried, N; Stein, DJ; Temmingh, HS; Williams, T	1
Bogers, JPAM; Broekman, TG; de Haan, L; Moleman, P; Schulte, PFJ	1
Crespo-Facorro, B; Gómez-Revuelta, M; González-Pinto, A; Juncal-Ruiz, M; Ortiz-García de la Foz, V; Pelayo-Terán, JM; Vázquez-Bourgon, J	1
Bottlender, R; Jäger, M; Laux, G; Möller, HJ; Musil, R; Obermeier, M; Riedel, M; Schennach, R; Schmauss, M; Spellmann, I	1
Bellavia, A; Centorrino, F; Fitzmaurice, G; Jackson, JW; Valeri, L	1
Adams, CE; Kwong, JS; Nyakyoma, K; Qi, F; Sinclair, DJ; Zhao, S	1
Borlido, C; Caravaggio, F; Deluca, V; Graff-Guerrero, A; Ismail, Z; Mamo, D; Mulsant, B; Pollock, B; Remington, G; Suzuki, T; Uchida, H	1
Crespo-Facorro, B; Martínez-Garcia, O; Mata, I; Ortiz-Garcia de la Foz, V; Pérez-Iglesias, R; Valdizan, EM; Vazquez-Barquero, JL	1
Deng, H; Gao, C; Karayal, ON; Li, K; Pan, S; Shi, J; Shu, L; Tang, H; Vanderburg, D; Wang, G; Wang, X; Xie, S; Xu, X; Zhang, H; Zhao, J	1
El-Sayeh, HG; Hunger, H; Khanna, P; Komossa, K; Leucht, S; Rummel-Kluge, C; Schwarz, S	1
Arnold, JG; Cañive, JM; Miller, AL; Mintz, J; Rosenheck, RA; Swartz, MS	1
Bruni, C	1
Calabrese, JR; Gao, K; Karayal, ON; Kolluri, S; Pappadopulos, E	1
Chen, H; Fang, M; Ou, J; Shao, P; Wu, R; Xu, Y; Zhao, J	1
Rossi, A; Stratta, P	1
Bies, RR; Graff-Guerrero, A; Mamo, DC; Mimura, M; Pollock, BG; Suzuki, T; Tsuboi, T; Uchida, H	1
Achtyes, ED; Buckley, P; Bustillo, JR; Citrome, L; Gil, R; Goff, DC; Macklin, EA; Manschreck, TC; McEvoy, JP; Mech, AW	1
Hong, JP; Kim, MS; Park, S; Yi, KK	1
Li, CH; Rao, SZ; Shi, L; Zhan, GL; Zhang, H	1
Bies, RR; Mamo, DC; Mimura, M; Moriguchi, S; Pollock, BG; Remington, G; Suzuki, T; Uchida, H; Watanabe, K	1
Bobes García, J; de la Gándara Martín, JJ; Gutiérrez Fraile, M	1
Hugdahl, K; Johnsen, E; Jørgensen, HA; Kroken, RA; Løberg, EM; Sinkeviciute, I	1
Cavuş, I; DelBello, MP; Findling, RL; Gundapaneni, BK; Pappadopulos, E; Schwartz, JH; Vanderburg, DG	1
Koplewicz, HS	1
Abenavoli, E; Bruno, A; Lamberti Castronuovo, E; Micò, U; Muscatello, MR; Pandolfo, G; Scimeca, G; Spina, E; Zoccali, R	1
Asmal, L; Flegar, SJ; Komossa, K; Leucht, S; Rummel-Kluge, C; Wang, J	1
Citrome, L; Czobor, P; Van Dorn, RA; Volavka, J	1
Lin, H; Rosenheck, R	1
Aida, SA; Hatim, A; Mohamed, Z; Reynolds, GP; Roffeei, SN; Said, MA; Zainal, NZ	1
Dai, G; Zhang, Y	1
Awad, G; Hassan, M; Hsu, J; Loebel, A; Pikalov, A; Rajagopalan, K	1
Chue, P; Mandel, FS; Therrien, F	1
Eng, SM; Fleischhacker, WW; Geier, J; Kane, JM; Karayal, O; Kolluri, S; Reynolds, RF; Strom, BL	1
Aguglia, E; Bianchini, O; Cannavò, D; De Ronchi, D; Nespeca, C; Porcelli, S; Serretti, A; Trappoli, A	1
Jiang, Y; McGinnis, JJ; Ni, W	1
Choi, SH; Jung, BJ; Jung, WY; Kang, DH; Kim, SG; Lee, JS; Lee, YM; Shin, DH	1
Kuntz, KM; Park, T	1
Albers, LJ; Conca, A; Mandrioli, R; Mercolini, L; Protti, M; Raggi, MA	1
Balaban, E; Cwikel-Hamzany, S; Fostick, L; Juven-Wetzler, A; Zohar, J	1
Buckley, PF	1
Brennan, MD; Ramsey, TL	1
Mandrioli, R; Mercolini, L; Protti, M	1
Crespo-Facorro, B; Prieto, C; Sainz, J	1
Caravaggio, F; Chung, JK; Fervaha, G; Gerretsen, P; Graff-Guerrero, A; Iwata, Y; Mihashi, Y; Mulsant, B; Nakajima, S; Plitman, E; Remington, G; Takeuchi, H	1
Geerts, H; Potkin, S; Roberts, P; Spiros, A	1
Iskandar, JW; Kablinger, A; Kavuru, B; Vance, JE	1
Lin, H; McEvoy, J; Mohamed, S; Rosenheck, RA; Stroup, S; Swartz, M	1
Fleischhacker, WW; Karayal, ON; Kemmler, G; Kolluri, S; Vanderburg, D; Widschwendter, CG	1
Eddings, W; Franklin, JM; Kesselheim, AS; Landon, J; Wang, B	1
Alonso-Martín, C; Arias-Loste, MT; Crespo, J; Crespo-Facorro, B; Fábrega, E; Martínez-García, O; Morlán-Coarasa, MJ; Ortiz-García de la Foz, V; Romero-Gómez, M	1
Álvarez-García, R; Baca-García, E; Barrigón, ML; Berrouiguet, S; Brandt, SA; Carballo, JJ; Courtet, P; Lenca, P; Ovejero-García, S	1
Bai, YH; Cai, M; Chen, YC; Guo, L; McAlonan, GM; Tan, QR; Wang, HH; Wang, HN; Wang, Y; Wu, WJ; Zhang, RG; Zhang, YH; Zhang, ZJ	1
Loebel, A; Meyer, N; Rajagopalan, K; Wade, S	1
Bentaleb, LA; Cherbal, A; Luck, D; Lungu, O; Stip, E; Zhornitsky, S	1
Hamilton, J; Heaton, C; Lannan, R; Lavedan, C; Licamele, L; Mack, K; Polymeropoulos, MH; Thompson, A; Volpi, S; Wolfgang, CD	1
Hamilton, JB; Heaton, C; Lannan, R; Lavedan, C; Licamele, L; Mack, K; Polymeropoulos, MH; Volpi, S; Wolfgang, CD	1
Sikich, L	1
Daumit, GL; Davis, SM; Davis, VG; Goff, DC; Hsiao, J; Lieberman, JA; McEvoy, JP; Meyer, JM; Nasrallah, HA; Stroup, TS; Swartz, MS	1
Romeo, F; Rossi, A; Tiradritti, P; Vita, A	1
Dressing, H; Krumm, B; Kuwilsky, A; Zink, M	1
Fusar-Poli, RR	1
Chen, CK; Chen, HK; Tzeng, NS	1
Alvarez, Jdo N; Carvalho, Rde C; Frussa-Filho, R; Fukushiro, DF; Ribeiro, LT; Ricardo, VP	1
Montejo, AL; Rico-Villademoros, F	1
Haug, HJ; Kolb, SA; Koponen, H; Lublin, H; Sigmundsson, T	1
DelBello, MP; Ice, K; Keller, D; Miceli, J; Versavel, M	1
Loebel, A; O'Gorman, CJ; Simpson, GM; Yang, R	1
Bartenstein, P; Boy, C; Bröcheler, A; Buchholz, HG; Cumming, P; Fellows, C; Gründer, G; Hiemke, C; Janouschek, H; Landvogt, C; Rösch, F; Schäfer, W; Spreckelmeyer, K; Vernaleken, I; Veselinovic, T; Wong, DF	1
Kang, SG; Kim, H; Lee, HJ; Lee, KJ; Lee, SH; Park, YM	1
Alderman, JA; Gandelman, K; Glue, P; LaBadie, RR; Lombardo, I; Preskorn, SH; Versavel, M	1
Addington, DE; Johnson, G; Kulkarni, J; Labelle, A; Loebel, A; Mandel, FS	1
Harvey, PD; Kremer, CM; Lombardo, I; Pappadopulos, E	1
Blasey, C; Davis, JM; Kraemer, H; Lieberman, JA; Reaven, GM; Schatzberg, AF; Sethuraman, G; Tsuang, MT	1
Galluzzo, A; Gorini, B; Romeo, F; Sacchetti, E; Valsecchi, P; Warrington, L	2
Borba, CP; Boxill, R; Cather, C; Copeland, PM; Evins, AE; Fan, X; Forstbauer, SI; Freudenreich, O; Goff, DC; Henderson, DC; Miley, K; Sharma, B	1
Allison, DB; Giller, E; Loebel, A; Parsons, B; Romano, S; Siu, C; Williams, K	1
Ascher-Svanum, H; Ball, T; Conley, R; Liu, L; Stauffer, V	1
Díaz-Marsá, M; Rico-Villademoros, F; Sánchez, S	1
Citrome, L; Glue, P; Karayal, ON; Yang, R	1
Loebel, AD; Potkin, SG; Siu, CO; Warrington, LE; Watsky, EJ; Weiden, PJ	1
Goldberg, TE; Gomar, JJ	1
Akkaya, C; Alptekin, K; Brook, S; Danaci, AE; El Tallawy, H; Hafez, J; Karayal, ON; Lowe, W; Tzebelikos, E; Ucok, A	1
Buitelaar, JK; Grootens, KP; Kahn, RS; Peuskens, J; Sabbe, BG; Thys, E; van Veelen, NM; Verkes, RJ	1
Lavedan, C; Licamele, L; Malhotra, AK; Potkin, SG; Volpi, S	1
Barbui, C; Boso, M; Cipriani, A	1
Coskun, O; Dalkiran, M; Duran, A; Emul, M; Keles, I; Tosun, M; Ugur, M; Yavuz, R	1
Citrome, L; Jaffe, A; Levine, J	1
Citrome, L	4
Kuehn, BM	1
Camargos, ST; Cardoso, FE; Prais, HA; Viana, Bde M	1
Aberg, K; Adkins, DE; Lieberman, JA; McClay, JL; Perkins, DO; Stroup, S; Sullivan, PF; van den Oord, EJ; Vladimirov, VI	1
Dadić-Hero, E; Knez, R; Medved, P; Petrić, D; Ruzić, K	1
Bhoopathi, PS; Hunger, H; Kissling, W; Komossa, K; Leucht, S; Rummel-Kluge, C; Schwarz, S	1
Citrome, L; Cuffel, B; Harnett, J; Lenhart, G; Montejano, LB; Palmer, L; Reist, C; Sanders, KN	1
Herman, BK; Lawson, WB; Lazariciu, I; Loebel, A; Malik, M	1
DelBello, MP; Keller, D; Stewart, M; Versavel, M	1
Lavedan, C; Thompson, A; Volpi, S	1
Hunger, H; Kissling, W; Komossa, K; Leucht, S; Rummel-Kluge, C; Schmid, F; Schwarz, S; Silveira da Mota Neto, JI	1
Hunger, H; Kissling, W; Komossa, K; Leucht, S; Rummel-Kluge, C; Schmid, F; Schwarz, S; Srisurapanont, M	1
Anziano, R; Harrigan, RH; Miceli, JJ; O'Gorman, C; Shiovitz, T; Tensfeldt, TG	1
Burns, T; Derks, EM; Fleischhacker, WW; Gaebel, W; Kahn, RS; Riesbeck, M; Rössler, W; von Wilmsdorff, M	1
Duggan, L; Hunger, H; Kissling, W; Komossa, K; Leucht, S; Rummel-Kluge, C; Schmid, F; Schwarz, S	1
Peitl, MV; Peitl, V; Petrić, D	1
Benedetti, AM; Frazee, LA; Leung, JG; Myers, N	1
Anziano, RJ; Harrigan, RH; Miceli, JJ; O'Gorman, C; Shiovitz, T; Tensfeldt, TG	1
Bacalis, S; Chatziioannou, S; Douzenis, A; Fotiadis, C; Katsantoni, E; Lykouras, L; Mandrapilia, A; Rizos, EN; Siafakas, N	1
Potvin, S; Stip, E; Tourjman, V; Zhornitsky, S	1
Grootens, KP; Kahn, RS; Peuskens, J; Sabbe, BG; Salden, ME; Sitskoorn, MM; van Veelen, NM; Verkes, RJ	1
Bae, KY; Kim, JM; Kim, SW; Shin, IS; Yang, SJ; Yoon, JS	1
Lincoln, J; Preskorn, SH; Stewart, ME	1
Harvey, PD; Loebel, A; Malla, A; Newcomer, JW; Potkin, SG; Romano, S; Siu, CO; Stahl, SM; Watsky, E; Weiden, PJ	1
Grignon, S; Roy-Desruisseaux, J	1
Cañas, F; Fagiolini, A; Gallhofer, B; Larmo, I; Levy, P; Montes, JM; Papageorgiou, G; Rossi, A; Zink, M	1
Davis, JM; Hunger, H; Kissling, W; Komossa, K; Leucht, S; Lobos, CA; Rummel-Kluge, C; Schmid, F; Schwarz, S	1
Campbell, EC; Caroff, SN; Chakos, MH; Davis, SM; Davis, VG; Keefe, RS; Lieberman, JA; McEvoy, JP; Miller, DD; Riggio, S; Rosenheck, RA; Saltz, BL; Stroup, TS; Swartz, MS	1
Buitelaar, JK; Grootens, KP; Kahn, RS; Peuskens, J; Sabbe, BG; Sitskoorn, MM; van Veelen, NM; Verkes, RJ	1
D'Agostino, RB; Eng, SM; Faich, G; Kane, JM; Reynolds, RF; Ruskin, J; Strom, BL	1
Asenjo Lobos, C; Hunger, H; Komossa, K; Leucht, S; Rummel-Kluge, C; Schmid, F; Schwarz, S	1
Case, M; Conley, RR; Hoffmann, VP; Jacobson, JG; Stauffer, VL	1
Abi-Dargham, A; Cangiano, C; Frankle, WG; Gil, R; Huang, Y; Hwang, DR; Kegeles, LS; Laruelle, M; Lombardo, I; Martin, JH; Reich, E; Slifstein, M	1
Celikyurt, IK; Erden, FB; Kayir, H; Ulak, G; Ulusoy, GK; Uzbay, TI	1
Mandel, FS; Masand, P; O'Gorman, C	1
Bies, RR; Coley, K; Kirshner, MM; Li, CH; Lieberman, JA; Marder, SR; Pollock, BG; Schneider, LS; Stroup, S; Wessels, AM	1
Hunger, H; Kissling, W; Komossa, K; Leucht, S; Rummel-Kluge, C; Schmid, F; Schwarz, S	1
Cucchiaro, J; Harvey, PD; Keefe, RS; Loebel, A; Ogasa, M	1
Cañas, F; Correll, CU; Fagiolini, A; Larmo, I; Levy, P; Montes, JM; Papageorgiou, G; Rossi, A; Sturlason, R; Zink, M	1
Stroup, TS	1
Bobo, WV; Crystal, S; Gerhard, T; Huang, C; Lieberman, JA; Olfson, M	1
Bachinsky, M; Cavus, I; Chappell, P; Glue, P; Karayal, ON; Kolluri, S; Stewart, M	1
Montes, JM	1
Dadić-Hero, E; Grahovac, T; Palijan, TZ; Petranović, D; Ružić, K; Sepić-Grahovac, D	1
Anway, SD; Batzar, E; Karayal, ON; Vanderburg, DG	1
Hasnain, M; Vieweg, WV	1
Mautone, A; Scarone, S	1
Camm, JA; Eng, S; Geier, JL; Karayal, ON; Keane, M; Kolluri, S; Kremer, CM; Lewis, M; Reynolds, R; Strom, BL	1
Alvir, JM; Crabtree, BL; Cuffel, BJ; Dostrow, VG; Evans, CJ; Sanders, KN	1
Bitter, I; Czobor, P; Derks, EM; Fleischhacker, WW; Kahn, RS; Libiger, J; Volavka, J	1
Cucchiaro, J; Loebel, A; Ogasa, M; Potkin, SG	1
Jakovljevic, M; Mihaljevic-Peles, A; Muck-Seler, D; Mustapic, M; Nedic, G; Nikolac, M; Pivac, N; Sagud, M; Vuksan Cusa, B	1
Lerner, V; Miodownik, C; Witztum, E	1
Citrome, L; Hochfeld, M; Meng, X; Stahl, SM	1
Dudova, I; Hrdlicka, M; Urbanek, T; Zedkova, I	1
Kaushik, S; Khan, A; Lindenmayer, JP; Parakadavil, M; Smith, RC; Tedeschi, F; Yusim, A	1
Berkowitz, RL; Docherty, JP; Ni, Q; Parks, JJ; Patel, U	1
Bobo, WV; Chen, Y; Jayathilake, K; Meltzer, HY; Tang, T; Watts, K	1
Ascher-Svanum, H; Bruhn, D; Graham, CN; Lawson, AH; Mauskopf, JA	1
Li, YM; Ou, JJ; Wu, RR; Zhao, JP	1
Bies, RR; Keefe, RS; Mamo, DC; Mimura, M; Pollock, BG; Rajji, TK; Sakurai, H; Stroup, ST; Suzuki, T; Uchida, H; Watanabe, K	1
Hu, SH; Tao, J; Wang, JH; Wu, XL	1
Camm, AJ; Kane, JM; Karayal, ON; Kolluri, S; Meltzer, H; Miceli, J; O'Gorman, C; Tensfeldt, T	1
Sun, J; Xu, H; Zhao, Z	1
Mencacci, C	1
Bitter, I; Bucci, P; Fleischhacker, WW; Galderisi, S; Kahn, RS; Libiger, J; Mucci, A	1
Kolluri, S; Newcomer, JW; Pappadopulos, E	1
Cho, YM; Jeong, SW; Jung, H; Kim, JH; Kwak, SN; Kwon, OJ; Lee, KW; Oh, JE	1
Alvir, JM; Berger, A; Edelsberg, J; Mychaskiw, MA; Oster, G; Sanders, KN	1
Moteshafi, H; Stip, E	1
Chen, HH; Fan, X; Gao, K; Guo, XF; Ou, JJ; Wang, J; Wu, RR; Xu, Y; Zhao, JP	1
Alvarez, E; Arranz, B; Corripio, I; Dueñas, R; Perez, V; Ramirez, N; Safont, G; San, L	1
Agid, O; Pappadopulos, E; Remington, G; Siu, CO; Vanderburg, D	1
Eng, SM; Faich, G; Kane, JM; Kolitsopoulos, FM; Reynolds, RF; Strom, BL	1
Buchmann, J; Häßler, F; Höppner, J; Pohl, B; Reis, O; Weirich, S	1
Piazzi, G; Sciarretta, A	1
Cutler, AJ; Kalali, AH; Kunovac, J; Mattingly, GW; Meng, X	1
Gunasekara, NS; Keating, GM; Spencer, CM	2
Mack, JE; Reeves, RR	1
Arato, M; Meltzer, HY; O'Connor, R	1
Jessen, LM	1
Bellnier, TJ	1
Kimble, R; Reeves, RR	1
Kaye, NS	1
Taylor, D	1
Nolan, BP; Schulte, JJ	1
O'Sullivan, RL; Potkin, SG; Simpson, GM; Weiden, PJ	1
Woods, SW	1
Jensen, PN; Stenstrøm, AD	1
Hauser, A; Larson, MF	1
Lieberman, JA; Stroup, TS	1
Harvey, PD; Romano, S; Siu, CO	1
Daniel, DG; Romano, SJ; Simpson, G; Weiden, PJ	1
Kropp, S; Schomerus, G; Ziegenbein, M	1
Tamminga, CA	1
Kane, JM	3
Shayegan, DK; Stahl, SM	2
Brook, S	1
Schooler, NR	1
Harvey, PD	1
Daniel, DG	1
Mandrioli, R; Pucci, V; Raggi, MA; Sabbioni, C	1
Buckley, PF; Glazer, W; Sebastian, CS	1
Berardi, D; De Ronchi, D; Lorenzi, C; Serretti, A	1
Bitter, I	1
Harvey, PD; Loebel, A; Meltzer, H; Potkin, SG; Romano, SJ; Simpson, GM; Siu, C	1
Lublin, HK	1
Findling, RL; McNamara, NK	1
Loebel, A; Romano, S; Siu, C	1
Buchanan, RW; Buckley, PF; Chiles, JA; Conley, RR; Crismon, ML; Ereshefsky, L; Essock, SM; Finnerty, M; Hall, CS; Marder, SR; McEvoy, JP; Miller, A; Miller, DD; Rush, AJ; Saeed, SA; Schooler, NR; Shon, SP; Stroup, S; Tarin-Godoy, B	1
Kapur, S; Mamo, D; Mann, S; Papatheodorou, G; Remington, G; Shammi, CM; Therrien, F	1
Gaszner, G; Kosza, P	1
Assion, HJ; Schwenkreis, P	1
Dressing, H; Mase, E; Zink, M	1
Andersen, MP; Hogg, S; Pouzet, B	1
Glick, ID; Romano, SJ; Simpson, GM; Siu, CO; Weiden, PJ	1
Baldessarini, RJ; Berry, JM; Centorrino, F; Fogarty, KV; Kidwell, JE; MacLean, E; Salvatore, P	1
Byerly, M; Carmody, T; Holland, R; Li, B; Miller, DR; Montgomery, JH; Varghese, F	1
Addington, DE; Benattia, I; Dineen, M; Pantelis, C; Romano, SJ	1
Ananth, J; Burgoyne, KS; Niz, D; Smith, M	1
Benattia, I; Brook, S; Romano, SJ; Siu, CO; Walden, J	1
Brown, RR; Estoup, MW	1
Bowie, CR; Harvey, PD	1
Härtter, S; Hiemke, C; Sachse, J	1
Baldassano, C; Ballas, C; Ballas, P; O'Reardon, J; Yang, C	1
Cosi, C; Newman-Tancredi, A; Rollet, K; Tesori, V; Waget, A	1
Bartholomä, A; Gregor, A; Hein, J; Heinz, A; Juckel, G	1
Baker, TM; Matza, LS; Revicki, DA	1
Matsui-Sakata, A; Ohtani, H; Sawada, Y	1
Christensen, JD; Garver, DL; Holcomb, JA	1
Ross, DE	1
Carnahan, RM; Perry, PJ	1
Hwang, JP; Tsai, CF; Tsai, SJ	1
Murray, S; Pigott, T; Romano, SJ; Simpson, GM; Siu, CO; Weiden, P	1
Davis, CE; Davis, SM; Hsiao, JK; Keefe, RS; Lebowitz, BD; Lieberman, JA; McEvoy, JP; Perkins, DO; Rosenheck, RA; Severe, J; Stroup, TS; Swartz, MS	1
Berg, PH; Breier, A; Cavazzoni, P; Gattaz, WF; Kane, JM; Naber, D; Roychowdhury, SM; Thakore, JH; Walker, DJ	1
Jayathilake, K; Meltzer, HY; Roy, A; Sumiyoshi, C; Sumiyoshi, T	1
Giller, E; Kane, JM; Khanna, S; Rajadhyaksha, S	1
Bozikas, VP; Fokas, K; Garyfallos, G; Giouzepas, J; Nikolaidis, N; Xomalis, D	1
Annable, L; Beauclair, L; Chouinard, G; Kolivakis, TT; Margolese, HC; Miller, R	1
Adams, DH; Kinon, BJ; Liu-Seifert, H	1
Daniel, DG; Harvey, PD; Kilts, CD; Lieberman, JA; Nemeroff, CB; Newcomer, JW; Schatzberg, AF; Weiden, PJ	1
Blow, FC; Dalack, GW; Ignacio, RV; McCarthy, JF; Stavenger, T; Valenstein, M	1
Luchins, DJ	1
Hsiao, JK; Lieberman, JA	1
Banks, SM; Pandiani, JA	1
Anghelescu, IG; Dettling, M	1
Bossie, CA; Canuso, CM; Gharabawi, GM; Greenspan, A; Lasser, RA; Mahmoud, R; Turkoz, I	1
Stone, AM	1
Bowie, CR; Harvey, PD; Loebel, A	1
Murray, S; Olié, JP; Spina, E; Yang, R	1
Canive, JM; Khan, A; Lieberman, JA; McEvoy, JP; McGee, M; Miller, DD; Reimherr, F; Rosenheck, RA; Stroup, TS; Swanson, JW; Swartz, MS; Van Dorn, R; Wagner, HR	1
Birinyi-Strachan, L; Davey, P; Kongsakon, R; Leelahanaj, T; Price, N	1
Carter, CT; Harrison, DJ; Joyce, AT; Loebel, AD; Ollendorf, DA	1
Harrison, DJ; Mullins, CD; Naradzay, J; Obeidat, N; Shaya, FT; Zito, JM	1
Davis, CE; Davis, SM; Hsiao, JK; Keefe, RS; Lieberman, JA; McEvoy, JP; Meltzer, HY; Perkins, DO; Rosenheck, RA; Severe, J; Stroup, TS; Swartz, MS	1
Davis, CE; Davis, SM; Hsiao, JK; Keefe, RS; Lieberman, JA; McEvoy, JP; Perkins, DO; Rosenheck, RA; Severe, J; Stroup, TS; Swartz, MS	1
Chou, YH; Ku, HL; Su, TP	1
Adams, DH; Ascher-Svanum, H; Edwards, SB; Kinon, BJ; Lipkovich, I; Siris, SG	1
Brook, S; Citrome, L; Czobor, P; Loebel, A; Mandel, FS; Volavka, J	1
Alvarez, E; Barrachina, J; Campins, MJ; Madre, M; Pascual, JC; Pérez, V; Soler, J	1
Bowie, C; Green, MF; Harvey, PD; Loebel, A	1
Barak, Y; Baruch, Y; Mazeh, D; Plopski, I	1
Akkaya, C; Kirli, S; Kotan, Z; Sarandol, A; Sivrioglu, EY	1
Bates, JA; Burdick, KE; Kane, JM; Malhotra, AK; Razi, K; Sanders, M	1
Campbell, L; Cato, KJ; Clarke, K; Davies, CH; Gordon, L; Gribble, A; Heath, J; Jones, DN; Patel, N; Riley, G; Scott, C; Wood, MD; Worby, A	1
Bies, RR; Chew, ML; Gharabawi, G; Greenspan, A; Kapur, S; Kirshner, MA; Lehman, ME; Mulsant, BH; Pollock, BG	1
de Leon, J; Diaz, FJ; Markham-Abedi, C; McNeely, C; Villanueva, N	1
Gianfrancesco, FD; Rajagopalan, K; Sajatovic, M; Wang, RH	1
Baumgartner, S; Ebenbichler, C; Edlinger, M; Fleischhacker, WW; Hofer, A; Hummer, M; Kemmler, G; Lechleitner, M; Rettenbacher, MA	1
Naber, D; Phillips, GA; Roychowdhury, SM; Van Brunt, DL; Xu, W	1
Correll, CU; Frederickson, AM; Kane, JM; Manu, P	1
Aravagiri, M; Marder, SR; Pollock, B	1
Adams, DH; Citrome, L; Kinon, BJ; Liu-Seifert, H	1
Gil, R; Girgis, RR; Rosenfield, PJ	1
Balbo, E; Delgado, JF; Diez, T; Martin, E; Montes, JM; Rodriguez, JL; Sopelana, P; Soto, JA; Villardaga, I	1
Scott, LJ; Swainston Harrison, T	1
Domin, S; Kasper, S; Kudla, D; Lambert, M; Naber, D	1
Bernardo, M; Ramón Azanza, J; Rejas, J; Rubio-Terrés, C	1
De Oliveira, IR; Juruena, MF	1
Bartkó, G; Bitter, I; Degrell, I; Faludi, G; Füredi, J; Trixler, M	1
Capuano, G; Davis, SM; Hsiao, JK; Keefe, RS; Lieberman, JA; McEvoy, JP; McGee, MF; Perkins, DO; Reimherr, F; Rosenheck, RA; Stroup, TS; Swartz, MS	1
Cansel, N; Herken, H; Ozen, ME; Savas, HA; Yumru, M	1
Aukst-Margetic, B; Margetic, B	1
Bowie, CR; Buckley, PF; Harvey, PD; Loebel, A	1
Colasanti, A; Dragogna, F; Fiorentini, A; Mauri, MC; Papa, P; Rossattini, M; Valli, A; Volonteri, LS	1
Bilder, RM; Capuano, G; Davis, CE; Davis, SM; Gold, JM; Green, MF; Harvey, PD; Hsiao, JK; Keefe, RS; Lieberman, JA; McEvoy, JP; Meltzer, HY; Palmer, BW; Perkins, DO; Rosenheck, RA; Stroup, TS; Swartz, MS	1
Goodman, C; Silver, H	1
Cuffel, BJ; Loebel, AD; Mullins, CD; Naradzay, J; Obeidat, NA	1
Citrome, L; Greenberg, WM	1
Gibel, A; Ratner, Y; Ritsner, MS; Soifer, P; Yorkov, V	1
Gibel, A; Ratner, Y; Ritsner, MS; Yorkov, V	1
Cañas, F; Díaz, S; Pérez-Solá, V; Rejas, J	1
Wooten, J	1
Chua, SE; Chung, AK	1
Giller, E; Khanna, S; Loebel, AD; Potkin, SG; Rajadhyaksha, S; Siu, CO	1
Loebel, A; Siu, C; Warrington, L; Yang, R; Zimbroff, D	1
Allen, MH; Nordstrom, K	1
Bick, P; Castle, D; Knoesen, N	1
Neill, JC; Snigdha, S	1
de Leon, J; Markham-Abedi, C; McNeely, C	1
Bilder, RM; Galluzzo, A; Gorini, B; Harvey, PD; Loebel, AD; Romeo, F; Sacchetti, E	1
Calabrese, JR; Gajwani, P; Ganocy, SJ; Gao, K; Kemp, DE; Muzina, DJ	1
Alvarez, E; Pascual, JC; Pérez, V; Pérez-Egea, R; Puigdemont, D; Soler, J; Tiana, T	1
D'Agostino, RB; Eng, SM; Faich, GA; Kane, JM; Reynolds, RF; Ruskin, JN; Strom, BL	1
Cutler, AJ; Hamilton, J; Kalali, AH; Weiden, PJ; Wolfgang, CD	1
Boter, H; Davidson, M; Dollfus, S; Fleischhacker, WW; Gaebel, W; Galderisi, S; Gheorghe, MD; Grobbee, DE; Hranov, LG; Hummer, M; Kahn, RS; Keet, IP; Libiger, J; Lindefors, N; López-Ibor, JJ; Peuskens, J; Riecher-Rössler, A; Rybakowski, JK; Vergouwe, Y	1
Allingham, B; Citrome, L; Jaffe, A; Levine, J; Martello, D	1
Davis, SM; Hsiao, JK; Keefe, RS; Lieberman, JA; McEvoy, JP; Rosenheck, RA; Stroup, TS; Swartz, MS	1
Washburn, CF	1
Lahti, AC; Tamminga, CA	1
Goff, DC; Herz, L; Kletti, N; Ko, GN; Lapierre, K; Law, CG; Posever, T; Simmons, J; Wilner, KD	1
Buffenstein, A; Feighner, J; Ferguson, J; Harrigan, EP; Jaffe, W; Keck, P; Morrissey, MR	1
Daniel, DG; Harrigan, EP; Lakshminarayanan, M; Potkin, SG; Reeves, KR; Zimbroff, DL	1
Allison, DB; Cappelleri, JC; Chandler, LP; Cheskin, LJ; Fontaine, KR; Heo, M; Mentore, JL; Weiden, PJ	1
Awad, AG; Voruganti, LN	1
Keck, PE; McElroy, SL; Strakowski, SM	1
Bagnall, A; Kleijnen, J; Leitner, ML; Lewis, RA	1
Möller, HJ	1
Bagnall, A; Leitner, ML; Lewis, RA	1
Copeland, LF; Daniel, DG	1
Kapur, S; Remington, G	1
Hilger, E; Kasper, S	1
Harrigan, EP; Lesem, MD; Reeves, KR; Swift, RH; Zajecka, JM	1
Casey, DE; Zorn, SH	1
Carnahan, RM; Lund, BC; Perry, PJ	1
Fayek, M; Kingsbury, SJ; Simpson, GM; Trufasiu, D; Zada, J	1
Hirsch, M	1
Arnold, LM; Keck, PE; McElroy, SL	1
Sussman, N	1
Green, B	1
Gutierrez, MA; Lee, V; Stimmel, GL	1
Albert, MJ; Baldessarini, RJ; Centorrino, F; Kelleher, JP	1
Caley, CF; Cooper, CK	1
Bäuml, J; Hirsch, SR; Kissling, W; O'Connor, R; Power, A	1

Reviews

75 review(s) available for ziprasidone and Dementia Praecox

Article	Year
Current and novel approaches to the drug treatment of schizophrenia. Journal of medicinal chemistry, 2001, Feb-15, Volume: 44, Issue:4 Topics: Animals; Antipsychotic Agents; Cholinergic Agonists; Disease Models, Animal; Dopamine Antagonists; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Humans; Mice; Mice, Transgenic; Nitric Oxide Synthase; Receptor, Serotonin, 5-HT2A; Receptors, AMPA; Receptors, Dopamine D2; Receptors, Dopamine D4; Receptors, Metabotropic Glutamate; Receptors, N-Methyl-D-Aspartate; Receptors, Neurotensin; Receptors, Serotonin; Schizophrenia; Serotonin Antagonists	2001
Dose-Response Meta-Analysis of Antipsychotic Drugs for Acute Schizophrenia. The American journal of psychiatry, 2020, 04-01, Volume: 177, Issue:4 Topics: Acute Disease; Administration, Oral; Antipsychotic Agents; Aripiprazole; Clozapine; Delayed-Action Preparations; Dose-Response Relationship, Drug; Haloperidol; Humans; Imidazoles; Indoles; Isoxazoles; Lurasidone Hydrochloride; Olanzapine; Paliperidone Palmitate; Piperazines; Piperidines; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Schizophrenic Psychology; Thiazoles; Thiophenes	2020
The metabolic side effects of 12 antipsychotic drugs used for the treatment of schizophrenia on glucose: a network meta-analysis. BMC psychiatry, 2017, 11-21, Volume: 17, Issue:1 Topics: Antipsychotic Agents; Benzodiazepines; Blood Glucose; Humans; Insulin; Lurasidone Hydrochloride; Network Meta-Analysis; Olanzapine; Piperazines; Risperidone; Schizophrenia; Thiazoles	2017
Risperidone versus other antipsychotics for people with severe mental illness and co-occurring substance misuse. The Cochrane database of systematic reviews, 2018, Jan-22, Volume: 1 Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Diagnosis, Dual (Psychiatry); Humans; Mental Disorders; Olanzapine; Patient Dropouts; Perphenazine; Piperazines; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Substance-Related Disorders; Thiazoles	2018
Electroconvulsive therapy for treatment-resistant schizophrenia. The Cochrane database of systematic reviews, 2019, 03-19, Volume: 3 Topics: Adult; Antipsychotic Agents; Brief Psychiatric Rating Scale; Electroconvulsive Therapy; Female; Flupenthixol; Humans; Male; Memory Disorders; Patient Readmission; Piperazines; Randomized Controlled Trials as Topic; Schizophrenia; Standard of Care; Thiazoles; Treatment Outcome	2019
Aripiprazole versus other atypical antipsychotics for schizophrenia. The Cochrane database of systematic reviews, 2013, Feb-28, Issue:2 Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Humans; Olanzapine; Piperazines; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Thiazoles	2013
Risk for adverse events and discontinuation due to adverse events of ziprasidone monotherapy relative to placebo in the acute treatment of bipolar depression, mania, and schizophrenia. Journal of clinical psychopharmacology, 2013, Volume: 33, Issue:3 Topics: Antipsychotic Agents; Bipolar Disorder; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Humans; Piperazines; Randomized Controlled Trials as Topic; Schizophrenia; Sleep Stages; Thiazoles; Weight Gain	2013
Quetiapine versus other atypical antipsychotics for schizophrenia. The Cochrane database of systematic reviews, 2013, Nov-18, Issue:11 Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Medication Adherence; Olanzapine; Piperazines; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Thiazoles	2013
Evaluation of the pharmacokinetics, safety and clinical efficacy of ziprasidone for the treatment of schizophrenia and bipolar disorder. Expert opinion on drug metabolism & toxicology, 2015, Volume: 11, Issue:1 Topics: Animals; Antipsychotic Agents; Bipolar Disorder; Disorders of Excessive Somnolence; Dizziness; Drug Evaluation; Humans; Piperazines; Schizophrenia; Thiazoles; Treatment Outcome	2015
Efficacy of atypical antipsychotics in early-onset schizophrenia and other psychotic disorders. The Journal of clinical psychiatry, 2008, Volume: 69 Suppl 4 Topics: Adolescent; Adult; Age of Onset; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Brain Diseases; Child; Chronic Disease; Clozapine; Comorbidity; Disease Progression; Humans; Magnetic Resonance Imaging; Olanzapine; Piperazines; Prognosis; Psychotic Disorders; Quinolones; Schizophrenia; Thiazoles; Treatment Failure	2008
Clozapine combined with different antipsychotic drugs for treatment resistant schizophrenia. The Cochrane database of systematic reviews, 2009, 07-08, Issue:3 Topics: Amisulpride; Antipsychotic Agents; Clozapine; Dibenzothiazepines; Drug Resistance; Drug Therapy, Combination; Female; Humans; Male; Piperazines; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Sulpiride; Thiazoles	2009
Using oral ziprasidone effectively: the food effect and dose-response. Advances in therapy, 2009, Volume: 26, Issue:8 Topics: Administration, Oral; Antipsychotic Agents; Biological Availability; Bipolar Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Monitoring; Energy Intake; Food-Drug Interactions; Humans; Injections, Intramuscular; Intestinal Absorption; Piperazines; Safety; Schizophrenia; Thiazoles; Treatment Outcome	2009
Ziprasidone versus other atypical antipsychotics for schizophrenia. The Cochrane database of systematic reviews, 2009, Oct-07, Issue:4 Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Sulpiride; Thiazoles	2009
Amisulpride versus other atypical antipsychotics for schizophrenia. The Cochrane database of systematic reviews, 2010, Jan-20, Issue:1 Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Humans; Olanzapine; Piperazines; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Sulpiride; Thiazoles	2010
Quetiapine versus other atypical antipsychotics for schizophrenia. The Cochrane database of systematic reviews, 2010, Jan-20, Issue:1 Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Medication Adherence; Olanzapine; Piperazines; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Thiazoles	2010
Olanzapine versus other atypical antipsychotics for schizophrenia. The Cochrane database of systematic reviews, 2010, Mar-17, Issue:3 Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Sulpiride; Thiazoles	2010
Strategies for successful clinical management of schizophrenia with ziprasidone. Expert opinion on pharmacotherapy, 2010, Volume: 11, Issue:13 Topics: Antipsychotic Agents; Comorbidity; Humans; Piperazines; Randomized Controlled Trials as Topic; Risk Factors; Schizophrenia; Thiazoles; Treatment Outcome	2010
Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis. Schizophrenia research, 2010, Volume: 123, Issue:2-3 Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Blood Glucose; Cholesterol; Clinical Trials as Topic; Clozapine; Dibenzothiazepines; Humans; Imidazoles; Indoles; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Sulpiride; Thiazoles; Weight Gain	2010
Clozapine versus other atypical antipsychotics for schizophrenia. The Cochrane database of systematic reviews, 2010, Nov-10, Issue:11 Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Dibenzothiepins; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Thiazoles	2010
Risperidone versus other atypical antipsychotics for schizophrenia. The Cochrane database of systematic reviews, 2011, Jan-19, Issue:1 Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Imidazoles; Indoles; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Sulpiride; Thiazoles	2011
Drug safety evaluation of ziprasidone. Expert opinion on drug safety, 2011, Volume: 10, Issue:3 Topics: Antipsychotic Agents; Bipolar Disorder; Clinical Trials as Topic; Drug-Related Side Effects and Adverse Reactions; Humans; Long QT Syndrome; Piperazines; Schizophrenia; Thiazoles	2011
Ziprasidone and the corrected QT interval: a comprehensive summary of clinical data. CNS drugs, 2012, Apr-01, Volume: 26, Issue:4 Topics: Administration, Oral; Adult; Antipsychotic Agents; Bipolar Disorder; Child; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Clinical Trials, Phase IV as Topic; Dose-Response Relationship, Drug; Electrocardiography; Humans; Long QT Syndrome; Piperazines; Randomized Controlled Trials as Topic; Schizophrenia; Thiazoles	2012
Changes in weight, plasma lipids, and glucose in adults treated with ziprasidone: a comprehensive analysis of pfizer-initiated clinical trials. The Journal of clinical psychiatry, 2012, Volume: 73, Issue:6 Topics: Antipsychotic Agents; Bipolar Disorder; Blood Glucose; Body Mass Index; Body Weight; Clinical Trials as Topic; Drug Industry; Fasting; Humans; Lipids; Piperazines; Psychotic Disorders; Randomized Controlled Trials as Topic; Schizophrenia; Thiazoles; Time Factors	2012
Comparing tolerability profile of quetiapine, risperidone, aripiprazole and ziprasidone in schizophrenia and affective disorders: a meta-analysis. Expert opinion on drug safety, 2012, Volume: 11, Issue:5 Topics: Adult; Affective Disorders, Psychotic; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Dibenzothiazepines; Humans; Hypercholesterolemia; Incidence; Pharmacovigilance; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Thiazoles	2012
Spotlight on ziprasidone in schizophrenia and schizoaffective disorder. CNS drugs, 2002, Volume: 16, Issue:9 Topics: Antipsychotic Agents; Humans; Piperazines; Psychotic Disorders; Randomized Controlled Trials as Topic; Schizophrenia; Thiazoles; Treatment Outcome	2002
Continuum of care: stabilizing the acutely agitated patient. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2002, Sep-01, Volume: 59, Issue:17 Suppl 5 Topics: Antipsychotic Agents; Benzodiazepines; Clinical Trials as Topic; Continuity of Patient Care; Cost-Benefit Analysis; Drug Therapy, Combination; Economics, Pharmaceutical; Humans; Olanzapine; Piperazines; Pirenzepine; Psychomotor Agitation; Schizophrenia; Thiazoles; Treatment Outcome	2002
Ziprasidone in the management of schizophrenia : the QT interval issue in context. CNS drugs, 2003, Volume: 17, Issue:6 Topics: Antipsychotic Agents; Electrocardiography; Female; Humans; Long QT Syndrome; Male; Piperazines; Risk Assessment; Risk Factors; Schizophrenia; Sex Factors; Thiazoles; Torsades de Pointes	2003
Chlorpromazine equivalent doses for the newer atypical antipsychotics. The Journal of clinical psychiatry, 2003, Volume: 64, Issue:6 Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Chlorpromazine; Dibenzothiazepines; Dose-Response Relationship, Drug; Drug Administration Schedule; Haloperidol; Humans; Olanzapine; Piperazines; Pirenzepine; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Therapeutic Equivalency; Thiazoles	2003
The psychopharmacology of ziprasidone: receptor-binding properties and real-world psychiatric practice. The Journal of clinical psychiatry, 2003, Volume: 64 Suppl 19 Topics: Animals; Antipsychotic Agents; Brain; Clinical Trials as Topic; Dopamine; Humans; Membrane Glycoproteins; Membrane Transport Proteins; Neuropeptides; Piperazines; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D2; Schizophrenia; Schizophrenic Psychology; Serotonin; Serotonin Antagonists; Thiazoles; Vesicular Biogenic Amine Transport Proteins	2003
Intramuscular ziprasidone: moving beyond the conventional in the treatment of acute agitation in schizophrenia. The Journal of clinical psychiatry, 2003, Volume: 64 Suppl 19 Topics: Acute Disease; Antipsychotic Agents; Brief Psychiatric Rating Scale; Dose-Response Relationship, Drug; Humans; Injections, Intramuscular; Piperazines; Psychomotor Agitation; Randomized Controlled Trials as Topic; Schizophrenia; Schizophrenic Psychology; Serotonin Antagonists; Thiazoles; Treatment Outcome	2003
Oral ziprasidone in the treatment of schizophrenia: a review of short-term trials. The Journal of clinical psychiatry, 2003, Volume: 64 Suppl 19 Topics: Administration, Oral; Antipsychotic Agents; Double-Blind Method; Humans; Piperazines; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Schizophrenia; Schizophrenic Psychology; Serotonin Antagonists; Thiazoles; Treatment Outcome	2003
Maintaining symptom control: review of ziprasidone long-term efficacy data. The Journal of clinical psychiatry, 2003, Volume: 64 Suppl 19 Topics: Antipsychotic Agents; Clinical Trials as Topic; Humans; Long-Term Care; Piperazines; Schizophrenia; Schizophrenic Psychology; Serotonin Antagonists; Thiazoles; Treatment Outcome	2003
Tolerability of ziprasidone: an expanding perspective. The Journal of clinical psychiatry, 2003, Volume: 64 Suppl 19 Topics: Administration, Oral; Antipsychotic Agents; Clinical Trials as Topic; Dose-Response Relationship, Drug; Humans; Injections, Intramuscular; Long-Term Care; Piperazines; Schizophrenia; Schizophrenic Psychology; Serotonin Antagonists; Thiazoles	2003
Atypical antipsychotics: pharmacokinetics, therapeutic drug monitoring and pharmacological interactions. Current medicinal chemistry, 2004, Volume: 11, Issue:3 Topics: Antipsychotic Agents; Benzodiazepines; Chemistry, Pharmaceutical; Clinical Trials as Topic; Clozapine; Cytochrome P-450 Enzyme System; Dibenzothiazepines; Drug Interactions; Drug Monitoring; Humans; Molecular Structure; Olanzapine; Piperazines; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles	2004
Naturalistic studies of second generation antipsychotics in the treatment of schizophrenia. Current medicinal chemistry, 2004, Volume: 11, Issue:3 Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clinical Trials as Topic; Clozapine; Dibenzothiazepines; Humans; Olanzapine; Patient Compliance; Piperazines; Polypharmacy; Quetiapine Fumarate; Quinolones; Research Design; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome	2004
New antipsychotics and schizophrenia: a review on efficacy and side effects. Current medicinal chemistry, 2004, Volume: 11, Issue:3 Topics: Antipsychotic Agents; Benzodiazepines; Clinical Trials as Topic; Cognition; Dibenzothiazepines; Drug Interactions; Humans; Olanzapine; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome	2004
[Current pharmacotherapy of schizophrenia]. Orvosi hetilap, 2004, Jan-18, Volume: 145, Issue:3 Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Risperidone; Schizophrenia; Serotonin Antagonists; Sulpiride; Thiazoles	2004
[Ziprasidone. A new second-generation antipsychotic agent]. Ugeskrift for laeger, 2004, Mar-29, Volume: 166, Issue:14 Topics: Administration, Oral; Antipsychotic Agents; Dopamine Antagonists; Humans; Injections, Intramuscular; Piperazines; Psychotic Disorders; Schizophrenia; Serotonin Antagonists; Thiazoles	2004
Atypical antipsychotics in the treatment of children and adolescents: clinical applications. The Journal of clinical psychiatry, 2004, Volume: 65 Suppl 6 Topics: Adolescent; Age Factors; Antipsychotic Agents; Attention Deficit and Disruptive Behavior Disorders; Benzodiazepines; Bipolar Disorder; Child; Child Development Disorders, Pervasive; Clozapine; Dibenzothiazepines; Humans; Mental Disorders; Olanzapine; Piperazines; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles; Tic Disorders	2004
The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2003 update. The Journal of clinical psychiatry, 2004, Volume: 65, Issue:4 Topics: Algorithms; Ambulatory Care; Ambulatory Care Facilities; Antipsychotic Agents; Aripiprazole; Clozapine; Decision Trees; Drug Administration Schedule; Drug Therapy, Combination; Humans; Piperazines; Practice Guidelines as Topic; Quinolones; Schizophrenia; Schizophrenic Psychology; Texas; Thiazoles; Treatment Outcome	2004
[Paralytic ileus during haloperidol therapy]. Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology, 2004, Volume: 6, Issue:1 Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Fatal Outcome; Haloperidol; Humans; Intestinal Pseudo-Obstruction; Male; Piperazines; Schizophrenia; Schizophrenic Psychology; Thiazoles	2004
Atypical antipsychotics and diabetes mellitus. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2004, Volume: 5, Issue:2 Topics: Antipsychotic Agents; Benzodiazepines; Diabetes Mellitus; Dibenzothiazepines; Glucose; Humans; Insulin Resistance; Islets of Langerhans; Obesity; Olanzapine; Pancreas; Piperazines; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles	2004
An analysis of the effect of funding source in randomized clinical trials of second generation antipsychotics for the treatment of schizophrenia. Controlled clinical trials, 2004, Volume: 25, Issue:6 Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Double-Blind Method; Drug Industry; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Research Support as Topic; Retrospective Studies; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome	2004
Ziprasidone: efficacy, tolerability, and emerging data on wide-ranging effectiveness. Expert opinion on pharmacotherapy, 2005, Volume: 6, Issue:2 Topics: Antipsychotic Agents; Chemistry, Pharmaceutical; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Tolerance; Humans; Piperazines; Schizophrenia; Thiazoles	2005
Ziprasidone: a novel psychotropic with unique properties. Expert review of neurotherapeutics, 2004, Volume: 4, Issue:2 Topics: Antipsychotic Agents; Clinical Trials as Topic; Humans; Mental Disorders; Piperazines; Schizophrenia; Thiazoles	2004
Efficacy of olanzapine and ziprasidone for the treatment of schizophrenia: a systematic review. CNS drugs, 2005, Volume: 19, Issue:6 Topics: Antipsychotic Agents; Benzodiazepines; Drug Evaluation; Humans; Meta-Analysis as Topic; Olanzapine; Piperazines; Schizophrenia; Thiazoles	2005
Tardive dyskinesia in the era of typical and atypical antipsychotics. Part 2: Incidence and management strategies in patients with schizophrenia. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2005, Volume: 50, Issue:11 Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Dibenzothiazepines; Dyskinesia, Drug-Induced; Humans; Incidence; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Thiazoles	2005
Discontinuation of treatment of schizophrenic patients is driven by poor symptom response: a pooled post-hoc analysis of four atypical antipsychotic drugs. BMC medicine, 2005, Dec-23, Volume: 3 Topics: Adult; Analysis of Variance; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Female; Humans; Male; Middle Aged; Olanzapine; Patient Dropouts; Piperazines; Psychiatric Status Rating Scales; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Schizophrenic Psychology; Thiazoles; Treatment Failure; Treatment Refusal	2005
Differential rates of treatment discontinuation in clinical trials as a measure of treatment effectiveness for olanzapine and comparator atypical antipsychotics for schizophrenia. Journal of clinical psychopharmacology, 2006, Volume: 26, Issue:6 Topics: Adult; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Double-Blind Method; Female; Humans; Male; Olanzapine; Patient Dropouts; Piperazines; Psychiatric Status Rating Scales; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Research Design; Risperidone; Schizophrenia; Schizophrenic Psychology; Thiazoles; Treatment Failure; Treatment Outcome	2006
Ziprasidone: a review of its use in schizophrenia and schizoaffective disorder. CNS drugs, 2006, Volume: 20, Issue:12 Topics: Antipsychotic Agents; Area Under Curve; Humans; Injections, Intramuscular; Long QT Syndrome; Piperazines; Psychotic Disorders; Schizophrenia; Tablets; Thiazoles; Treatment Outcome	2006
Treatment of psychosis: 30 years of progress. Journal of clinical pharmacy and therapeutics, 2006, Volume: 31, Issue:6 Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Olanzapine; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Receptors, Dopamine; Receptors, Serotonin; Risperidone; Schizophrenia; Thiazoles	2006
Ziprasidone for schizophrenia and bipolar disorder: a review of the clinical trials. CNS drug reviews, 2007,Summer, Volume: 13, Issue:2 Topics: Affective Symptoms; Antipsychotic Agents; Bipolar Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Longitudinal Studies; Piperazines; Randomized Controlled Trials as Topic; Schizophrenia; Thiazoles; Treatment Outcome	2007
Metabolic effects of the atypical antipsychotics. Southern medical journal, 2007, Volume: 100, Issue:8 Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Diabetes Mellitus; Dibenzothiazepines; Dyslipidemias; Glucose Metabolism Disorders; Humans; Insulin Resistance; Mental Disorders; Obesity; Olanzapine; Phenothiazines; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Thiazoles	2007
Managing the acutely agitated and psychotic patient. CNS spectrums, 2007, Volume: 12, Issue:10 Suppl 1 Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Dibenzothiazepines; Emergencies; Humans; Olanzapine; Piperazines; Psychomotor Agitation; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Thiazoles	2007
Comparison of intramuscular ziprasidone, olanzapine, or aripiprazole for agitation: a quantitative review of efficacy and safety. The Journal of clinical psychiatry, 2007, Volume: 68, Issue:12 Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Double-Blind Method; Humans; Injections, Intramuscular; Olanzapine; Piperazines; Psychomotor Agitation; Quinolones; Randomized Controlled Trials as Topic; Schizophrenia; Thiazoles; Treatment Outcome	2007
A review of sensitivity and tolerability of antipsychotics in patients with bipolar disorder or schizophrenia: focus on somnolence. The Journal of clinical psychiatry, 2008, Volume: 69, Issue:2 Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Double-Blind Method; Haloperidol; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Research Design; Risperidone; Schizophrenia; Sleep Stages; Thiazoles; Treatment Outcome	2008
Problems with CATIE. Phase 1: Looking back--what the clinician needs to know. Connecticut medicine, 2008, Volume: 72, Issue:4 Topics: Antidepressive Agents, Second-Generation; Basal Ganglia Diseases; Benzodiazepines; Clinical Trials, Phase I as Topic; Cost-Benefit Analysis; Dibenzothiazepines; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risk; Risperidone; Schizophrenia; Thiazoles	2008
The new generation of antipsychotic drugs. International clinical psychopharmacology, 1996, Volume: 11 Suppl 2 Topics: Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Humans; Imidazoles; Indoles; Olanzapine; Piperazines; Pirenzepine; Quetiapine Fumarate; Schizophrenia; Thiazoles	1996
Tardive dyskinesia in affective disorders. The Journal of clinical psychiatry, 1999, Volume: 60 Suppl 5 Topics: Adult; Affective Disorders, Psychotic; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Carbamazepine; Controlled Clinical Trials as Topic; Dibenzothiazepines; Drug Administration Schedule; Dyskinesia, Drug-Induced; Female; Humans; Imidazoles; Indoles; Male; Olanzapine; Piperazines; Pirenzepine; Psychotic Disorders; Quetiapine Fumarate; Risk Assessment; Risk Factors; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome	1999
The efficacy of atypical antipsychotics in the treatment of depressive symptoms, hostility, and suicidality in patients with schizophrenia. The Journal of clinical psychiatry, 2000, Volume: 61 Suppl 3 Topics: Aggression; Antipsychotic Agents; Benzodiazepines; Clinical Trials as Topic; Clozapine; Depression; Depressive Disorder; Dibenzothiazepines; Hostility; Humans; Multicenter Studies as Topic; Olanzapine; Piperazines; Pirenzepine; Psychiatric Status Rating Scales; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Suicide; Thiazoles; Treatment Outcome	2000
Ziprasidone for schizophrenia and severe mental illness. The Cochrane database of systematic reviews, 2000, Issue:2 Topics: Antipsychotic Agents; Humans; Piperazines; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Thiazoles	2000
[New i.e. atypical neuroleptic agents for negative symptoms of schizophrenia: results and methodological problems of evaluation]. Der Nervenarzt, 2000, Volume: 71, Issue:5 Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Dibenzothiepins; Double-Blind Method; Dyskinesia, Drug-Induced; Humans; Imidazoles; Indoles; Neurotransmitter Agents; Olanzapine; Piperazines; Pirenzepine; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Schizophrenic Psychology; Sulpiride; Thiazoles	2000
Ziprasidone for schizophrenia and severe mental illness. The Cochrane database of systematic reviews, 2000, Issue:4 Topics: Antipsychotic Agents; Humans; Piperazines; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Thiazoles	2000
Ziprasidone: comprehensive overview and clinical use of a novel antipsychotic. Expert opinion on investigational drugs, 2000, Volume: 9, Issue:4 Topics: Animals; Antipsychotic Agents; Clinical Trials as Topic; Humans; Piperazines; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Serotonin Antagonists; Thiazoles	2000
Atypical antipsychotics: new directions and new challenges in the treatment of schizophrenia. Annual review of medicine, 2001, Volume: 52 Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Dibenzothiepins; Dopamine Antagonists; Drug Monitoring; Haloperidol; Humans; Imidazoles; Indoles; Olanzapine; Piperazines; Pirenzepine; Quetiapine Fumarate; Receptors, Dopamine D2; Receptors, Dopamine D4; Risperidone; Schizophrenia; Schizophrenic Psychology; Serotonin Antagonists; Sulpiride; Thiazoles; Treatment Outcome	2001
[Atypical neuroleptics: new approaches to drug therapy of schizophrenic disorders]. Wiener klinische Wochenschrift, 2000, Dec-22, Volume: 112, Issue:24 Topics: Aged; Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Controlled Clinical Trials as Topic; Dibenzothiazepines; Dibenzothiepins; Haloperidol; Humans; Imidazoles; Indoles; Multicenter Studies as Topic; Olanzapine; Piperazines; Pirenzepine; Placebos; Quetiapine Fumarate; Risperidone; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sulpiride; Thiazoles	2000
The pharmacology of weight gain with antipsychotics. The Journal of clinical psychiatry, 2001, Volume: 62 Suppl 7 Topics: Animals; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Eating; Humans; Olanzapine; Piperazines; Pirenzepine; Psychotic Disorders; Quetiapine Fumarate; Rats; Receptors, Neurotransmitter; Schizophrenia; Thiazoles; Weight Gain	2001
Ziprasidone, a new atypical antipsychotic drug. Pharmacotherapy, 2001, Volume: 21, Issue:6 Topics: Antipsychotic Agents; Bipolar Disorder; Clinical Trials as Topic; Drug Interactions; Humans; Piperazines; Psychotic Disorders; Schizophrenia; Thiazoles; Tourette Syndrome	2001
Ziprasidone: a new atypical antipsychotic. Expert opinion on pharmacotherapy, 2001, Volume: 2, Issue:6 Topics: Antipsychotic Agents; Benzodiazepines; Clinical Trials as Topic; Dibenzothiazepines; Dopamine Antagonists; Drug Interactions; Guidelines as Topic; Humans; Olanzapine; Piperazines; Pirenzepine; Quetiapine Fumarate; Risperidone; Schizophrenia; Serotonin Antagonists; Thiazoles; Time Factors; Tourette Syndrome	2001
Review of atypical antipsychotics and weight gain. The Journal of clinical psychiatry, 2001, Volume: 62 Suppl 23 Topics: Ambulatory Care; Antipsychotic Agents; Benzodiazepines; Body Mass Index; Clinical Trials as Topic; Clozapine; Dibenzothiazepines; Dose-Response Relationship, Drug; Hospitalization; Humans; Olanzapine; Piperazines; Pirenzepine; Quetiapine Fumarate; Research Design; Schizophrenia; Thiazoles; Weight Gain	2001
Focus on ziprasidone. Current medical research and opinion, 2001, Volume: 17, Issue:2 Topics: Antipsychotic Agents; Clinical Trials as Topic; Dopamine Antagonists; Humans; Piperazines; Psychotic Disorders; Schizophrenia; Serotonin Antagonists; Thiazoles; Treatment Outcome	2001
Ziprasidone: an atypical antipsychotic drug for the treatment of schizophrenia. Clinical therapeutics, 2002, Volume: 24, Issue:1 Topics: Administration, Oral; Antipsychotic Agents; Bipolar Disorder; Clinical Trials as Topic; Drug Interactions; Drug Overdose; Humans; Injections, Intramuscular; Piperazines; Psychotic Disorders; Schizophrenia; Thiazoles; Tourette Syndrome	2002
Advances in atypical antipsychotics for the treatment of schizophrenia: new formulations and new agents. CNS drugs, 2002, Volume: 16, Issue:4 Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clinical Trials as Topic; Clozapine; Dosage Forms; Humans; Isoxazoles; Olanzapine; Piperazines; Piperidines; Pirenzepine; Quinolones; Risperidone; Schizophrenia; Thiazoles	2002
Ziprasidone: the fifth atypical antipsychotic. The Annals of pharmacotherapy, 2002, Volume: 36, Issue:5 Topics: Acute Disease; Antipsychotic Agents; Basal Ganglia Diseases; Body Weight; Headache; Humans; Injections, Intramuscular; Long QT Syndrome; Nausea; Piperazines; Randomized Controlled Trials as Topic; Schizophrenia; Thiazoles; Treatment Outcome; Weight Gain	2002
Ziprasidone: a review of its use in schizophrenia and schizoaffective disorder. Drugs, 2002, Volume: 62, Issue:8 Topics: Administration, Oral; Antipsychotic Agents; Clinical Trials as Topic; Drug Interactions; Humans; Injections, Intramuscular; Piperazines; Psychotic Disorders; Schizophrenia; Thiazoles; Treatment Outcome	2002

Trials

143 trial(s) available for ziprasidone and Dementia Praecox

Article	Year
Low-Dose Ziprasidone in Combination with Sertraline for First-Episode Drug-Naïve Patients with Schizophrenia: a Randomized Controlled Trial. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2022, Volume: 19, Issue:3 Topics: Antipsychotic Agents; Double-Blind Method; Humans; Piperazines; Psychiatric Status Rating Scales; Schizophrenia; Sertraline; Thiazoles; Treatment Outcome	2022
Early Efficacy of Antipsychotic Medications at Week 2 Predicts Subsequent Responses at Week 6 in a Large-scale Randomized Controlled Trial. Current neuropharmacology, 2023, Volume: 21, Issue:2 Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Haloperidol; Humans; Olanzapine; Quetiapine Fumarate; Risperidone; Schizophrenia; Treatment Outcome	2023
Antipsychotic Treatment Effectiveness in First Episode of Psychosis: PAFIP 3-Year Follow-Up Randomized Clinical Trials Comparing Haloperidol, Olanzapine, Risperidone, Aripiprazole, Quetiapine, and Ziprasidone. The international journal of neuropsychopharmacology, 2020, 04-23, Volume: 23, Issue:4 Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Female; Follow-Up Studies; Haloperidol; Humans; Male; Olanzapine; Outcome Assessment, Health Care; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles; Young Adult	2020
Course of Psychosis in Schizophrenia With Alcohol Use Disorder: A Post Hoc Analysis of the Clinical Antipsychotic Trials of Intervention Effectiveness in Schizophrenia Phase 1 Study. The Journal of clinical psychiatry, 2020, 03-17, Volume: 81, Issue:2 Topics: Adult; Alcoholism; Antipsychotic Agents; Comorbidity; Female; Hospitalization; Humans; Male; Olanzapine; Outcome Assessment, Health Care; Perphenazine; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Severity of Illness Index; Symptom Flare Up; Thiazoles; Time Factors	2020
Metabolic Effects of 7 Antipsychotics on Patients With Schizophrenia: A Short-Term, Randomized, Open-Label, Multicenter, Pharmacologic Trial. The Journal of clinical psychiatry, 2020, 03-24, Volume: 81, Issue:3 Topics: Adult; Antipsychotic Agents; Aripiprazole; Blood Glucose; Cholesterol, HDL; Cholesterol, LDL; Female; Humans; Male; Metabolic Syndrome; Olanzapine; Piperazines; Quetiapine Fumarate; Risk Factors; Risperidone; Schizophrenia; Thiazoles; Triglycerides	2020
A 3-year prospective study on the metabolic effect of aripiprazole, quetiapine and ziprasidone: A pragmatic clinical trial in first episode psychosis patients. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2020, Volume: 39 Topics: Adult; Antipsychotic Agents; Aripiprazole; Energy Metabolism; Female; Follow-Up Studies; Humans; Longitudinal Studies; Male; Piperazines; Prospective Studies; Psychotic Disorders; Quetiapine Fumarate; Schizophrenia; Thiazoles; Time Factors; Weight Gain; Young Adult	2020
Incidence and risk factors of acute akathisia in 493 individuals with first episode non-affective psychosis: a 6-week randomised study of antipsychotic treatment. Psychopharmacology, 2017, Volume: 234, Issue:17 Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Female; Haloperidol; Humans; Incidence; Male; Olanzapine; Piperazines; Prospective Studies; Psychotic Disorders; Quetiapine Fumarate; Risk Factors; Risperidone; Schizophrenia; Thiazoles; Young Adult	2017
Dose reduction of high-dose first-generation antipsychotics or switch to ziprasidone in long-stay patients with schizophrenia: A 1-year double-blind randomized clinical trial. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2018, Volume: 28, Issue:9 Topics: Antipsychotic Agents; Chronic Disease; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Resistance; Female; Humans; Male; Middle Aged; Piperazines; Schizophrenia; Thiazoles; Treatment Outcome	2018
Long-Term Antipsychotic Effectiveness in First Episode of Psychosis: A 3-Year Follow-Up Randomized Clinical Trial Comparing Aripiprazole, Quetiapine, and Ziprasidone. The international journal of neuropsychopharmacology, 2018, 12-01, Volume: 21, Issue:12 Topics: Adult; Antipsychotic Agents; Aripiprazole; Female; Follow-Up Studies; Humans; Male; Outcome Assessment, Health Care; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Schizophrenia; Thiazoles; Young Adult	2018
Comparing Schizophrenia Patients With a Predicted High/Low Risk of Nonresponse Receiving Treatment with Ziprasidone and Haloperidol: A Randomized-Controlled Study. Pharmacopsychiatry, 2019, Volume: 52, Issue:4 Topics: Adult; Antipsychotic Agents; Double-Blind Method; Female; Haloperidol; Humans; Interpersonal Relations; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Risk Assessment; Schizophrenia; Severity of Illness Index; Thiazoles; Time Factors; Treatment Outcome	2019
The role of weight gain in explaining the effects of antipsychotic drugs on positive and negative symptoms: An analysis of the CATIE schizophrenia trial. Schizophrenia research, 2019, Volume: 206 Topics: Adult; Antipsychotic Agents; Body-Weight Trajectory; Female; Humans; Male; Middle Aged; Olanzapine; Perphenazine; Piperazines; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Thiazoles; Treatment Outcome; Weight Gain	2019
Dopamine D₂/₃ occupancy of ziprasidone across a day: a within-subject PET study. Psychopharmacology, 2013, Volume: 228, Issue:1 Topics: Adult; Antipsychotic Agents; Brain; Case-Control Studies; Dopamine Antagonists; Female; Half-Life; Humans; Male; Middle Aged; Piperazines; Positron-Emission Tomography; Prolactin; Raclopride; Receptors, Dopamine D2; Receptors, Dopamine D3; Schizophrenia; Thiazoles; Time Factors; Young Adult	2013
Aripiprazole, ziprasidone, and quetiapine in the treatment of first-episode nonaffective psychosis: results of a 6-week, randomized, flexible-dose, open-label comparison. Journal of clinical psychopharmacology, 2013, Volume: 33, Issue:2 Topics: Adult; Antipsychotic Agents; Aripiprazole; Dibenzothiazepines; Dose-Response Relationship, Drug; Female; Humans; Male; Piperazines; Prospective Studies; Quetiapine Fumarate; Quinolones; Schizophrenia; Thiazoles; Treatment Outcome; Young Adult	2013
Intramuscular ziprasidone versus haloperidol for managing agitation in Chinese patients with schizophrenia. Journal of clinical psychopharmacology, 2013, Volume: 33, Issue:2 Topics: Acute Disease; Adult; Antipsychotic Agents; China; Dose-Response Relationship, Drug; Female; Haloperidol; Humans; Injections, Intramuscular; Least-Squares Analysis; Male; Piperazines; Psychiatric Status Rating Scales; Psychomotor Agitation; Schizophrenia; Thiazoles; Time Factors; Young Adult	2013
[Effects of ziprasidone and olanzapine on glucose and lipid metabolism in first-episode schizophrenia]. Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2013, Volume: 38, Issue:4 Topics: Adolescent; Adult; Benzodiazepines; Blood Glucose; Female; Humans; Lipid Metabolism; Male; Middle Aged; Olanzapine; Piperazines; Schizophrenia; Thiazoles; Young Adult	2013
Hyperprolactinemia and estimated dopamine D2 receptor occupancy in patients with schizophrenia: analysis of the CATIE data. Progress in neuro-psychopharmacology & biological psychiatry, 2013, Aug-01, Volume: 45 Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Benzodiazepines; Female; Humans; Hyperprolactinemia; Male; Middle Aged; Olanzapine; Piperazines; Predictive Value of Tests; Prolactin; Receptors, Dopamine D2; Risperidone; Schizophrenia; Sensitivity and Specificity; Thiazoles	2013
High-dose oral ziprasidone versus conventional dosing in schizophrenia patients with residual symptoms: the ZEBRAS study. Journal of clinical psychopharmacology, 2013, Volume: 33, Issue:4 Topics: Adult; Antipsychotic Agents; Blood Pressure; Female; Humans; Long QT Syndrome; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Thiazoles; Time Factors; Treatment Outcome; United States	2013
Effects of ziprasidone and olanzapine on body composition and metabolic parameters: an open-label comparative pilot study. Behavioral and brain functions : BBF, 2013, Jul-19, Volume: 9 Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Appetite; Benzodiazepines; Body Composition; Body Weight; Cholesterol, HDL; Cholesterol, LDL; Energy Metabolism; Female; Humans; Male; Middle Aged; Olanzapine; Pilot Projects; Piperazines; Psychotic Disorders; Schizophrenia; Thiazoles; Weight Gain; Young Adult	2013
A twenty-four-week, open-label study on ziprasidone's efficacy and influence on glucolipid metabolism in patients with schizophrenia and metabolic disorder. European review for medical and pharmacological sciences, 2013, Volume: 17, Issue:16 Topics: Adult; Antipsychotic Agents; Blood Glucose; Blood Pressure; Body Mass Index; Cholesterol, HDL; Clozapine; Cognition Disorders; Female; Follow-Up Studies; Humans; Male; Metabolic Syndrome; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Schizophrenia; Thiazoles; Triglycerides	2013
Estimated dopamine D₂ receptor occupancy and remission in schizophrenia: analysis of the CATIE data. Journal of clinical psychopharmacology, 2013, Volume: 33, Issue:5 Topics: Adult; Antipsychotic Agents; Benzodiazepines; Brain; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Female; Humans; Male; Middle Aged; Nonlinear Dynamics; Olanzapine; Piperazines; Protein Binding; Psychiatric Status Rating Scales; Receptors, Dopamine D2; Remission Induction; Risperidone; Schizophrenia; Schizophrenic Psychology; Thiazoles; Time Factors; Treatment Outcome; United States	2013
Hallucinations in acutely admitted patients with psychosis, and effectiveness of risperidone, olanzapine, quetiapine, and ziprasidone: a pragmatic, randomized study. BMC psychiatry, 2013, Sep-30, Volume: 13 Topics: Adult; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Female; Hallucinations; Hospitalization; Humans; Male; Middle Aged; Olanzapine; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome	2013
Ziprasidone in adolescents with schizophrenia: results from a placebo-controlled efficacy and long-term open-extension study. Journal of child and adolescent psychopharmacology, 2013, Volume: 23, Issue:8 Topics: Adolescent; Antipsychotic Agents; Double-Blind Method; Early Termination of Clinical Trials; Female; Humans; Male; Piperazines; Placebos; Schizophrenia; Thiazoles; Treatment Outcome	2013
Augmentation of clozapine with ziprasidone in refractory schizophrenia: a double-blind, placebo-controlled study. Journal of clinical psychopharmacology, 2014, Volume: 34, Issue:1 Topics: Adult; Antipsychotic Agents; Clozapine; Cognition; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Electrocardiography; Female; Heart Rate; Humans; Italy; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Thiazoles; Time Factors; Treatment Outcome; Young Adult	2014
Effectiveness of antipsychotic drugs against hostility in patients with schizophrenia in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study. CNS spectrums, 2014, Volume: 19, Issue:5 Topics: Adult; Aggression; Amisulpride; Antipsychotic Agents; Benzodiazepines; Female; Haloperidol; Hostility; Humans; Male; Middle Aged; Olanzapine; Perphenazine; Piperazines; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Sulpiride; Thiazoles	2014
Noninferiority of perphenazine vs. three second-generation antipsychotics in chronic schizophrenia. The Journal of nervous and mental disease, 2014, Volume: 202, Issue:1 Topics: Adult; Aged; Antipsychotic Agents; Benzodiazepines; Chronic Disease; Dibenzothiazepines; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Olanzapine; Perphenazine; Piperazines; Quetiapine Fumarate; Risperidone; Sample Size; Schizophrenia; Thiazoles; Treatment Outcome	2014
Association of ADRA2A and MTHFR gene polymorphisms with weight loss following antipsychotic switching to aripiprazole or ziprasidone. Human psychopharmacology, 2014, Volume: 29, Issue:1 Topics: Adult; Alleles; Antipsychotic Agents; Aripiprazole; Body Mass Index; Female; Follow-Up Studies; Genotype; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Piperazines; Polymorphism, Genetic; Quinolones; Receptors, Adrenergic, alpha-2; Schizophrenia; Thiazoles; Weight Gain; Weight Loss	2014
Efﬁcacy and metabolic influence of paliperidone ER, aripiprazole and ziprasidone to patients with first-episode schizophrenia through 52 weeks follow-up in China. Human psychopharmacology, 2012, Volume: 27, Issue:6 Topics: Adult; Antipsychotic Agents; Aripiprazole; Body Mass Index; China; Delayed-Action Preparations; Diagnostic and Statistical Manual of Mental Disorders; Female; Follow-Up Studies; Humans; Hyperglycemia; Hyperlipidemias; Isoxazoles; Male; Metabolic Diseases; Paliperidone Palmitate; Piperazines; Psychiatric Status Rating Scales; Pyrimidines; Quinolones; Schizophrenia; Thiazoles; Weight Gain; Young Adult	2012
Health-related quality of life among patients treated with lurasidone: results from a switch trial in patients with schizophrenia. BMC psychiatry, 2014, Feb-23, Volume: 14 Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Dibenzothiazepines; Drug Substitution; Female; Humans; Isoindoles; Lurasidone Hydrochloride; Male; Middle Aged; Olanzapine; Outpatients; Piperazines; Quality of Life; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome	2014
The effect of ziprasidone on metabolic syndrome risk factors in subjects with schizophrenia: a 1 year, open-label, prospective study. Current medical research and opinion, 2014, Volume: 30, Issue:6 Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Humans; Male; Metabolic Syndrome; Middle Aged; Piperazines; Prospective Studies; Risk Factors; Schizophrenia; Thiazoles; Young Adult	2014
Completed and attempted suicides among 18,154 subjects with schizophrenia included in a large simple trial. The Journal of clinical psychiatry, 2014, Volume: 75, Issue:3 Topics: Adult; Antipsychotic Agents; Asia; Benzodiazepines; Europe; Female; Follow-Up Studies; Humans; Latin America; Male; Middle Aged; Olanzapine; Piperazines; Risk Factors; Schizophrenia; Suicide; Suicide, Attempted; Thiazoles; Time Factors; United States	2014
Open prospective study of ziprasidone in patients with schizophrenia with depressive symptoms: a multicenter study. Psychiatry and clinical neurosciences, 2015, Volume: 69, Issue:1 Topics: Adult; Antipsychotic Agents; Comorbidity; Depression; Female; Humans; Male; Middle Aged; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Schizophrenia; Thiazoles; Treatment Outcome	2015
Glucagon-like peptide 1 receptor (GLP1R) haplotypes correlate with altered response to multiple antipsychotics in the CATIE trial. Schizophrenia research, 2014, Volume: 160, Issue:1-3 Topics: Adult; Antipsychotic Agents; Benzodiazepines; Biomarkers, Pharmacological; Dibenzothiazepines; Female; Genotyping Techniques; Glucagon-Like Peptide-1 Receptor; Haplotypes; Humans; Male; Models, Genetic; Olanzapine; Perphenazine; Piperazines; Polymorphism, Single Nucleotide; Quetiapine Fumarate; Receptors, Glucagon; Regression Analysis; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome; Weight Gain; White People	2014
Schizophrenia gene expression profile reverted to normal levels by antipsychotics. The international journal of neuropsychopharmacology, 2014, Oct-31, Volume: 18, Issue:4 Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Female; Humans; Longitudinal Studies; Male; Olanzapine; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles; Transcriptome; Treatment Outcome	2014
Comparative efficacy between clozapine and other atypical antipsychotics on depressive symptoms in patients with schizophrenia: analysis of the CATIE phase 2E data. Schizophrenia research, 2015, Volume: 161, Issue:2-3 Topics: Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Chronic Disease; Clozapine; Depressive Disorder, Major; Double-Blind Method; Olanzapine; Piperazines; Psychiatric Status Rating Scales; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Thiazoles; Treatment Outcome	2015
Randomized Trial of the Effect of Four Second-Generation Antipsychotics and One First-Generation Antipsychotic on Cigarette Smoking, Alcohol, and Drug Use in Chronic Schizophrenia. The Journal of nervous and mental disease, 2015, Volume: 203, Issue:7 Topics: Adolescent; Adult; Aged; Alcoholism; Antipsychotic Agents; Benzodiazepines; Chronic Disease; Comorbidity; Cross-Sectional Studies; Dibenzothiazepines; Double-Blind Method; Female; Humans; Illicit Drugs; Male; Middle Aged; Olanzapine; Perphenazine; Piperazines; Psychiatric Status Rating Scales; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Smoking; Smoking Prevention; Substance-Related Disorders; Thiazoles; Young Adult	2015
Relating Spontaneously Reported Extrapyramidal Adverse Events to Movement Disorder Rating Scales. The international journal of neuropsychopharmacology, 2015, Jun-26, Volume: 18, Issue:12 Topics: Adolescent; Adult; Aged; Akathisia, Drug-Induced; Antipsychotic Agents; Double-Blind Method; Haloperidol; Humans; Middle Aged; Piperazines; Schizophrenia; Severity of Illness Index; Thiazoles; Young Adult	2015
Incidence of non-alcoholic fatty liver disease and metabolic dysfunction in first episode schizophrenia and related psychotic disorders: a 3-year prospective randomized interventional study. Psychopharmacology, 2016, Volume: 233, Issue:23-24 Topics: Adult; Antipsychotic Agents; Aripiprazole; Female; Humans; Incidence; Male; Metabolic Diseases; Middle Aged; Non-alcoholic Fatty Liver Disease; Piperazines; Prospective Studies; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles; Young Adult	2016
An assessor-blinded, randomized comparison of efficacy and tolerability of switching from olanzapine to ziprasidone and the combination of both in schizophrenia spectrum disorders. Journal of psychiatric research, 2017, Volume: 85 Topics: Administration, Oral; Adult; Antipsychotic Agents; Benzodiazepines; Drug Substitution; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Male; Metabolic Syndrome; Olanzapine; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Severity of Illness Index; Single-Blind Method; Thiazoles; Treatment Outcome; Weight Gain	2017
Association of the NPAS3 gene and five other loci with response to the antipsychotic iloperidone identified in a whole genome association study. Molecular psychiatry, 2009, Volume: 14, Issue:8 Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Basic Helix-Loop-Helix Transcription Factors; Double-Blind Method; Female; Genome-Wide Association Study; Glial Cell Line-Derived Neurotrophic Factor Receptors; Humans; Isoxazoles; Male; Middle Aged; Nerve Tissue Proteins; Pharmacogenetics; Piperazines; Piperidines; Polymorphism, Single Nucleotide; Pseudogenes; Receptors, AMPA; Schizophrenia; Tenascin; Thiazoles; Transcription Factors; Young Adult	2009
Whole genome association study identifies polymorphisms associated with QT prolongation during iloperidone treatment of schizophrenia. Molecular psychiatry, 2009, Volume: 14, Issue:11 Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Carrier Proteins; CELF Proteins; Cytoskeletal Proteins; Double-Blind Method; Electrocardiography; Female; Follow-Up Studies; Gene Frequency; Genome-Wide Association Study; Genotype; Humans; Intracellular Signaling Peptides and Proteins; Isoxazoles; Linear Models; Linkage Disequilibrium; Long QT Syndrome; Male; Middle Aged; Neuregulins; Organic Anion Transporters; Pharmacogenetics; Phosphoproteins; Phosphotransferases (Alcohol Group Acceptor); Piperazines; Piperidines; Polymorphism, Single Nucleotide; RNA-Binding Proteins; Schizophrenia; Thiazoles; Young Adult	2009
Impact of antipsychotic treatment on nonfasting triglycerides in the CATIE Schizophrenia Trial phase 1. Schizophrenia research, 2008, Volume: 103, Issue:1-3 Topics: Adult; Antipsychotic Agents; Benzodiazepines; Cardiovascular Diseases; Dibenzothiazepines; Female; Humans; Male; Middle Aged; Olanzapine; Perphenazine; Piperazines; Quetiapine Fumarate; Risk Factors; Risperidone; Schizophrenia; Thiazoles; Triglycerides	2008
Efficacy and tolerability of ziprasidone versus risperidone as augmentation in patients partially responsive to clozapine: a randomised controlled clinical trial. Journal of psychopharmacology (Oxford, England), 2009, Volume: 23, Issue:3 Topics: Adolescent; Adult; Antipsychotic Agents; Clozapine; Drug Therapy, Combination; Female; Humans; Long QT Syndrome; Male; Middle Aged; Piperazines; Prolactin; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Thiazoles; Treatment Outcome; Young Adult	2009
Changes in sexual function for outpatients with schizophrenia or other psychotic disorders treated with ziprasidone in clinical practice settings: a 3-month prospective, observational study. Journal of clinical psychopharmacology, 2008, Volume: 28, Issue:5 Topics: Adolescent; Adult; Antipsychotic Agents; Female; Humans; Male; Piperazines; Prospective Studies; Psychotic Disorders; Schizophrenia; Sexual Dysfunction, Physiological; Thiazoles	2008
Ziprasidone versus olanzapine, risperidone or quetiapine in patients with chronic schizophrenia: a 12-week open-label, multicentre clinical trial. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2009, Volume: 10, Issue:4 Pt 3 Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Benzodiazepines; Cholesterol; Chronic Disease; Dibenzothiazepines; Drug Tolerance; Female; Humans; Male; Middle Aged; Olanzapine; Piperazines; Prolactin; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles; Triglycerides; Young Adult	2009
Tolerability of oral ziprasidone in children and adolescents with bipolar mania, schizophrenia, or schizoaffective disorder. Journal of child and adolescent psychopharmacology, 2008, Volume: 18, Issue:5 Topics: Adolescent; Antipsychotic Agents; Bipolar Disorder; Child; Dose-Response Relationship, Drug; Electrocardiography; Female; Humans; Male; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Severity of Illness Index; Thiazoles	2008
Long-term improvement in efficacy and safety after switching to ziprasidone in stable outpatients with schizophrenia. CNS spectrums, 2008, Volume: 13, Issue:10 Topics: Adolescent; Adult; Ambulatory Care; Antipsychotic Agents; Female; Follow-Up Studies; Humans; Long-Term Care; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Thiazoles; Treatment Outcome; Young Adult	2008
Striatal and extrastriatal D2/D3-receptor-binding properties of ziprasidone: a positron emission tomography study with [18F]Fallypride and [11C]raclopride (D2/D3-receptor occupancy of ziprasidone). Journal of clinical psychopharmacology, 2008, Volume: 28, Issue:6 Topics: Adult; Antipsychotic Agents; Basal Ganglia; Benzamides; Binding, Competitive; Carbon Radioisotopes; Dopamine Antagonists; Dose-Response Relationship, Drug; Female; Fluorine Radioisotopes; Humans; Male; Piperazines; Positron-Emission Tomography; Pyrrolidines; Raclopride; Radiopharmaceuticals; Receptors, Dopamine D2; Receptors, Dopamine D3; Schizophrenia; Thiazoles; Time Factors; Young Adult	2008
The impact of calories and fat content of meals on oral ziprasidone absorption: a randomized, open-label, crossover trial. The Journal of clinical psychiatry, 2009, Volume: 70, Issue:1 Topics: Adult; Antipsychotic Agents; Biological Availability; Bipolar Disorder; Cross-Over Studies; Dietary Fats; Drug Administration Schedule; Energy Intake; Female; Food-Drug Interactions; Humans; Male; Middle Aged; Piperazines; Psychotic Disorders; Schizophrenia; Thiazoles; Young Adult	2009
A comparison of ziprasidone and risperidone in the long-term treatment of schizophrenia: a 44-week, double-blind, continuation study. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2009, Volume: 54, Issue:1 Topics: Adult; Antipsychotic Agents; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Female; Humans; Male; Piperazines; Risperidone; Schizophrenia; Severity of Illness Index; Thiazoles	2009
Reduction of functional disability with atypical antipsychotic treatment: a randomized long term comparison of ziprasidone and haloperidol. Schizophrenia research, 2009, Volume: 115, Issue:1 Topics: Adult; Antipsychotic Agents; Chi-Square Distribution; Cognition Disorders; Double-Blind Method; Female; Haloperidol; Humans; Longitudinal Studies; Male; Middle Aged; Neuropsychological Tests; Piperazines; Psychiatric Status Rating Scales; Schizophrenia; Thiazoles; Time Factors; Treatment Outcome	2009
In search of moderators and mediators of hyperglycemia with atypical antipsychotic treatment. Journal of psychiatric research, 2009, Volume: 43, Issue:11 Topics: Adult; Antipsychotic Agents; Benzodiazepines; Blood Glucose; Blood Pressure; Body Mass Index; Body Weight; Dose-Response Relationship, Drug; Female; Humans; Hyperglycemia; Lipid Metabolism; Lipoproteins, HDL; Male; Middle Aged; Olanzapine; Piperazines; Prediabetic State; Predictive Value of Tests; Randomized Controlled Trials as Topic; Schizophrenia; Thiazoles; Time Factors; Treatment Outcome	2009
Ziprasidone vs clozapine in schizophrenia patients refractory to multiple antipsychotic treatments: the MOZART study. Schizophrenia research, 2009, Volume: 110, Issue:1-3 Topics: Adult; Analysis of Variance; Antipsychotic Agents; Body Weight; Clozapine; Disease Progression; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Glucose; Humans; Italy; Lipids; Male; Middle Aged; Patient Compliance; Piperazines; Psychiatric Status Rating Scales; Quality of Life; Schizophrenia; Schizophrenic Psychology; Thiazoles; Young Adult	2009
Ziprasidone as an adjuvant for clozapine- or olanzapine-associated medical morbidity in chronic schizophrenia. Human psychopharmacology, 2009, Volume: 24, Issue:3 Topics: Adult; Antipsychotic Agents; Benzodiazepines; Blood Glucose; Body Mass Index; Body Weight; Chronic Disease; Clozapine; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hyperglycemia; Insulin Resistance; Male; Middle Aged; Morbidity; Olanzapine; Piperazines; Schizophrenia; Thiazoles; Time Factors	2009
Effectiveness and tolerability of oral ziprasidone in psychiatric inpatients with an acute exacerbation of schizophrenia or schizoaffective disorder: a multicenter, prospective, and naturalistic study. The Journal of clinical psychiatry, 2009, Volume: 70, Issue:4 Topics: Acute Disease; Adult; Antipsychotic Agents; Brief Psychiatric Rating Scale; Drug Administration Schedule; Female; Hospitalization; Humans; In Vitro Techniques; Length of Stay; Piperazines; Prospective Studies; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Thiazoles; Treatment Outcome	2009
Effect of ziprasidone dose on all-cause discontinuation rates in acute schizophrenia and schizoaffective disorder: a post-hoc analysis of 4 fixed-dose randomized clinical trials. Schizophrenia research, 2009, Volume: 111, Issue:1-3 Topics: Acute Disease; Adult; Antipsychotic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Piperazines; Proportional Hazards Models; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Thiazoles; Time Factors; Treatment Outcome	2009
Remission in schizophrenia: 196-week, double-blind treatment with ziprasidone vs. haloperidol. The international journal of neuropsychopharmacology, 2009, Volume: 12, Issue:9 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Double-Blind Method; Female; Haloperidol; Humans; Male; Middle Aged; Patient Dropouts; Piperazines; Psychiatric Status Rating Scales; Quality of Life; Remission Induction; Schizophrenia; Schizophrenic Psychology; Thiazoles; Time Factors; Treatment Outcome; Young Adult	2009
Efficacy and tolerability of switching to ziprasidone from olanzapine, risperidone or haloperidol: an international, multicenter study. International clinical psychopharmacology, 2009, Volume: 24, Issue:5 Topics: Adult; Aged; Antipsychotic Agents; Benzodiazepines; Drug Administration Schedule; Female; Haloperidol; Humans; Male; Middle Aged; Olanzapine; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Risperidone; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Thiazoles	2009
Ziprasidone vs olanzapine in recent-onset schizophrenia and schizoaffective disorder: results of an 8-week double-blind randomized controlled trial. Schizophrenia bulletin, 2011, Volume: 37, Issue:2 Topics: Adult; Alanine Transaminase; Antipsychotic Agents; Aspartate Aminotransferases; Basal Ganglia Diseases; Benzodiazepines; Biperiden; Blood Glucose; Body Weight; Cholesterol; Chronic Disease; Electrocardiography; Female; Humans; Male; Muscarinic Antagonists; Olanzapine; Piperazines; Prolactin; Psychiatric Status Rating Scales; Psychometrics; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Thiazoles; Triglycerides; Young Adult	2011
Applicability of a genetic signature for enhanced iloperidone efficacy in the treatment of schizophrenia. The Journal of clinical psychiatry, 2009, Volume: 70, Issue:6 Topics: Adult; Alleles; Antipsychotic Agents; Double-Blind Method; Female; Genetic Markers; Genotype; Humans; Isoxazoles; Likelihood Functions; Male; Middle Aged; Odds Ratio; Pharmacogenetics; Piperazines; Piperidines; Polymorphism, Single Nucleotide; Probability; Psychiatric Status Rating Scales; Psychometrics; Schizophrenia; Thiazoles; Treatment Outcome	2009
Ziprasidone vs clozapine in schizophrenia patients refractory to multiple antipsychotic treatments: the MOZART study. Schizophrenia research, 2009, Volume: 113, Issue:1 Topics: Adult; Analysis of Variance; Antipsychotic Agents; Body Weight; Clozapine; Disease Progression; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Glucose; Humans; Italy; Lipids; Male; Middle Aged; Patient Compliance; Piperazines; Psychiatric Status Rating Scales; Quality of Life; Schizophrenia; Schizophrenic Psychology; Thiazoles; Young Adult	2009
Genome-wide pharmacogenomic analysis of response to treatment with antipsychotics. Molecular psychiatry, 2011, Volume: 16, Issue:1 Topics: Antipsychotic Agents; Benzodiazepines; Chromosomes, Human, Pair 4; Dibenzothiazepines; Double-Blind Method; Follow-Up Studies; Genome-Wide Association Study; Humans; Olanzapine; Perphenazine; Pharmacogenetics; Piperazines; Polymorphism, Single Nucleotide; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome	2011
Ziprasidone in Black patients with schizophrenia: analysis of four short-term, double-blind studies. CNS spectrums, 2009, Volume: 14, Issue:9 Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Black People; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Thiazoles; Treatment Outcome; Young Adult	2009
Psychosocial functioning and health-related quality of life in children and adolescents treated with open-label ziprasidone for bipolar mania, schizophrenia, or schizoaffective disorder. Journal of child and adolescent psychopharmacology, 2009, Volume: 19, Issue:6 Topics: Adolescent; Antipsychotic Agents; Bipolar Disorder; Child; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Health Status; Humans; Male; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Quality of Life; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Social Behavior; Thiazoles; Treatment Outcome	2009
Absence of weight gain association with the HTR2C -759C/T polymorphism in patients with schizophrenia treated with iloperidone. Psychiatry research, 2010, Feb-28, Volume: 175, Issue:3 Topics: Analysis of Variance; Antipsychotic Agents; Female; Follow-Up Studies; Gene Frequency; Genotype; Humans; Isoxazoles; Male; Piperazines; Piperidines; Polymorphism, Genetic; Receptor, Serotonin, 5-HT2C; Schizophrenia; Thiazoles; Weight Gain	2010
Effects of Oral Ziprasidone and Oral Haloperidol on QTc interval in patients with Schizophrenia or Schizoaffective disorder. Pharmacotherapy, 2010, Volume: 30, Issue:2 Topics: Administration, Oral; Adult; Antipsychotic Agents; Dose-Response Relationship, Drug; Electrocardiography; Female; Haloperidol; Humans; Male; Middle Aged; Piperazines; Psychotic Disorders; Schizophrenia; Thiazoles	2010
Drug attitude as predictor for effectiveness in first-episode schizophrenia: Results of an open randomized trial (EUFEST). European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2010, Volume: 20, Issue:5 Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Female; Haloperidol; Humans; Male; Medication Adherence; Olanzapine; Piperazines; Psychiatric Status Rating Scales; Quetiapine Fumarate; ROC Curve; Schizophrenia; Schizophrenic Psychology; Sulpiride; Surveys and Questionnaires; Thiazoles; Treatment Outcome	2010
Effects of high-dose ziprasidone and haloperidol on the QTc interval after intramuscular administration: a randomized, single-blind, parallel-group study in patients with schizophrenia or schizoaffective disorder. Clinical therapeutics, 2010, Volume: 32, Issue:3 Topics: Adult; Aged; Antipsychotic Agents; Blood Pressure; Dose-Response Relationship, Drug; Electrocardiography; Female; Haloperidol; Heart Rate; Humans; Male; Middle Aged; Piperazines; Psychotic Disorders; Schizophrenia; Single-Blind Method; Thiazoles; Young Adult	2010
Switching from conventional antipsychotics to ziprasidone: a randomized, open-label comparison of regimen strategies. Progress in neuro-psychopharmacology & biological psychiatry, 2010, Aug-16, Volume: 34, Issue:6 Topics: Adult; Aged; Antipsychotic Agents; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Piperazines; Schizophrenia; Thiazoles; Treatment Outcome	2010
Short term neurocognitive effects of treatment with ziprasidone and olanzapine in recent onset schizophrenia. Schizophrenia research, 2010, Volume: 120, Issue:1-3 Topics: Adult; Antipsychotic Agents; Benzodiazepines; Cognition Disorders; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Neuropsychological Tests; Olanzapine; Piperazines; Quality of Life; Schizophrenia; Statistics as Topic; Thiazoles; Verbal Learning; Young Adult	2010
Effectiveness of switching from aripiprazole to ziprasidone in patients with schizophrenia. Clinical neuropharmacology, 2010, Volume: 33, Issue:3 Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Blood Glucose; Body Size; Body Weight; Diagnostic and Statistical Manual of Mental Disorders; Female; Hip; Humans; Hyperprolactinemia; Liver Function Tests; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Quinolones; Schizophrenia; Thiazoles; Treatment Outcome; Waist Circumference; Wakefulness; Young Adult	2010
A post hoc analysis of negative symptoms and psychosocial function in patients with schizophrenia: a 40-week randomized, double-blind study of ziprasidone versus haloperidol followed by a 3-year double-blind extension trial. Journal of clinical psychopharmacology, 2010, Volume: 30, Issue:4 Topics: Antipsychotic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Follow-Up Studies; Haloperidol; Humans; Piperazines; Psychiatric Status Rating Scales; Quality of Life; Remission Induction; Schizophrenia; Schizophrenic Psychology; Thiazoles; Time Factors; Treatment Outcome	2010
Treatment outcomes of patients with tardive dyskinesia and chronic schizophrenia. The Journal of clinical psychiatry, 2011, Volume: 72, Issue:3 Topics: Adult; Antipsychotic Agents; Benzodiazepines; Chi-Square Distribution; Dibenzothiazepines; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Movement Disorders; Olanzapine; Perphenazine; Piperazines; Proportional Hazards Models; Psychiatric Status Rating Scales; Quetiapine Fumarate; Risperidone; Schizophrenia; Severity of Illness Index; Thiazoles; Treatment Outcome	2011
Effects on cognitive functioning after olanzapine-ziprasidone crossover in recent-onset schizophrenia. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2010, Volume: 20, Issue:12 Topics: Acute Disease; Adolescent; Adult; Benzodiazepines; Cognition; Cross-Over Studies; Double-Blind Method; Drug Substitution; Female; Follow-Up Studies; Humans; Male; Neuropsychological Tests; Olanzapine; Piperazines; Schizophrenia; Schizophrenic Psychology; Thiazoles; Treatment Outcome; Young Adult	2010
Comparative mortality associated with ziprasidone and olanzapine in real-world use among 18,154 patients with schizophrenia: The Ziprasidone Observational Study of Cardiac Outcomes (ZODIAC). The American journal of psychiatry, 2011, Volume: 168, Issue:2 Topics: Adult; Antipsychotic Agents; Benzodiazepines; Cause of Death; Cross-Sectional Studies; Death, Sudden, Cardiac; Diabetic Ketoacidosis; Female; Hospitalization; Humans; Incidence; Kaplan-Meier Estimate; Long QT Syndrome; Male; Middle Aged; Myocardial Infarction; Olanzapine; Piperazines; Product Surveillance, Postmarketing; Prospective Studies; Risk; Schizophrenia; Suicide; Thiazoles	2011
Predictive value of early changes in triglycerides and weight for longer-term changes in metabolic measures during olanzapine, ziprasidone or aripiprazole treatment for schizophrenia and schizoaffective disorder post hoc analyses of 3 randomized, controll Journal of clinical psychopharmacology, 2010, Volume: 30, Issue:6 Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Blood Glucose; Cholesterol; Drug Monitoring; Female; Humans; Male; Middle Aged; Olanzapine; Piperazines; Quinolones; Schizophrenia; Thiazoles; Time Factors; Triglycerides; Weight Gain	2010
Population pharmacokinetic modeling of ziprasidone in patients with schizophrenia from the CATIE study. Journal of clinical pharmacology, 2011, Volume: 51, Issue:11 Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Double-Blind Method; Female; Humans; Male; Middle Aged; Piperazines; Schizophrenia; Thiazoles; Young Adult	2011
Performance and interview-based assessments of cognitive change in a randomized, double-blind comparison of lurasidone vs. ziprasidone. Schizophrenia research, 2011, Volume: 127, Issue:1-3 Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Cognition Disorders; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Interview, Psychological; Isoindoles; Lurasidone Hydrochloride; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Thiazoles; Young Adult	2011
Switching from quetiapine to ziprasidone: a sixteen-week, open-label, multicenter study evaluating the effectiveness and safety of ziprasidone in outpatient subjects with schizophrenia or schizoaffective disorder. Journal of psychiatric practice, 2011, Volume: 17, Issue:2 Topics: Adolescent; Adult; Antipsychotic Agents; Blood Glucose; Body Weight; Cholesterol; Cognition; Dibenzothiazepines; Drug Administration Schedule; Female; Glycated Hemoglobin; Humans; Male; Middle Aged; Outpatients; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Quetiapine Fumarate; Schizophrenia; Thiazoles; Treatment Outcome; Triglycerides; Young Adult	2011
Transition from ziprasidone im to oral formulation in agitated patients with acute exacerbation of schizophrenia: an open trial. Pharmacopsychiatry, 2011, Volume: 44, Issue:5 Topics: Administration, Oral; Adolescent; Adult; Antipsychotic Agents; Female; Humans; Injections, Intramuscular; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Psychomotor Agitation; Schizophrenia; Thiazoles	2011
Methodological challenges in the coding and adjudication of sudden deaths in a large simple trial with observational follow-up: the ziprasidone observational study of cardiac outcomes (ZODIAC). Pharmacoepidemiology and drug safety, 2011, Volume: 20, Issue:11 Topics: Antipsychotic Agents; Benzodiazepines; Cause of Death; Clinical Coding; Death, Sudden; Death, Sudden, Cardiac; Endpoint Determination; Follow-Up Studies; Heart; Humans; Incidence; International Classification of Diseases; Olanzapine; Piperazines; Product Surveillance, Postmarketing; Research Design; Risk; Schizophrenia; Sensitivity and Specificity; Surveys and Questionnaires; Thiazoles; Time Factors; United States; United States Food and Drug Administration	2011
Efficacy of antipsychotic drugs against hostility in the European First-Episode Schizophrenia Trial (EUFEST). The Journal of clinical psychiatry, 2011, Volume: 72, Issue:7 Topics: Adult; Aggression; Amisulpride; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Haloperidol; Hostility; Humans; Olanzapine; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Quetiapine Fumarate; Schizophrenia; Schizophrenic Psychology; Sulpiride; Thiazoles; Treatment Outcome	2011
Double-blind comparison of the safety and efficacy of lurasidone and ziprasidone in clinically stable outpatients with schizophrenia or schizoaffective disorder. Schizophrenia research, 2011, Volume: 132, Issue:2-3 Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Body Weight; Cholesterol; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Female; Humans; Isoindoles; Lurasidone Hydrochloride; Male; Middle Aged; Outpatients; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Thiazoles; Time Factors; Treatment Outcome; Triglycerides; Young Adult	2011
The lack of effect of ziprasidone on platelet serotonin concentration in schizophrenic patients. Psychopharmacology, 2012, Volume: 219, Issue:4 Topics: Antipsychotic Agents; Blood Platelets; Dose-Response Relationship, Drug; Female; Humans; Male; Piperazines; Psychotic Disorders; Schizophrenia; Serotonin; Serotonin Antagonists; Thiazoles; Time Factors	2012
Efficacy of iloperidone in the short-term treatment of schizophrenia: a post hoc analysis of pooled patient data from four phase III, placebo- and active-controlled trials. Human psychopharmacology, 2012, Volume: 27, Issue:1 Topics: Adolescent; Adult; Aged; Analysis of Variance; Antipsychotic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Labeling; Female; Haloperidol; Humans; Isoxazoles; Male; Middle Aged; Piperazines; Piperidines; Prospective Studies; Psychiatric Status Rating Scales; Psychotic Disorders; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome; Young Adult	2012
Comparative effectiveness of switching antipsychotic drug treatment to aripiprazole or ziprasidone for improving metabolic profile and atherogenic dyslipidemia: a 12-month, prospective, open-label study. Journal of psychopharmacology (Oxford, England), 2012, Volume: 26, Issue:9 Topics: Adult; Antipsychotic Agents; Aripiprazole; Atherosclerosis; Bipolar Disorder; Cohort Studies; Diagnostic and Statistical Manual of Mental Disorders; Drug Monitoring; Dyslipidemias; Female; Humans; Intention to Treat Analysis; Male; Middle Aged; North America; Patient Dropouts; Piperazines; Psychotic Disorders; Quinolones; Risk Factors; Schizophrenia; Severity of Illness Index; Thiazoles; Weight Loss	2012
Efficacy and tolerability of ziprasidone vs. olanzapine in naive first-episode schizophrenia: a 6-week, randomized, open-label, flexible-dose study. Pharmacopsychiatry, 2012, Volume: 45, Issue:5 Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Comparative Effectiveness Research; Dose-Response Relationship, Drug; Drug Monitoring; Episode of Care; Female; Humans; Male; Middle Aged; Olanzapine; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Thiazoles; Time Factors; Treatment Outcome; Weight Gain	2012
Dopamine D2 receptor occupancy and cognition in schizophrenia: analysis of the CATIE data. Schizophrenia bulletin, 2013, Volume: 39, Issue:3 Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Cognition Disorders; Dopamine D2 Receptor Antagonists; Female; Humans; Linear Models; Male; Middle Aged; Olanzapine; Piperazines; Receptors, Dopamine D2; Risperidone; Schizophrenia; Schizophrenic Psychology; Thiazoles; Young Adult	2013
Efficacy and tolerability of switching to ziprasidone in italian patients with acute exacerbation of schizophrenia: an open-label trial. Pharmacopsychiatry, 2012, Volume: 45, Issue:6 Topics: Adult; Antipsychotic Agents; Female; Humans; Long QT Syndrome; Male; Middle Aged; Patient Preference; Piperazines; Psychiatric Status Rating Scales; Schizophrenia; Thiazoles	2012
Persistent negative symptoms in first episode patients with schizophrenia: results from the European First Episode Schizophrenia Trial. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2013, Volume: 23, Issue:3 Topics: Adolescent; Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Cognition Disorders; Dibenzothiazepines; Female; Haloperidol; Humans; Male; Neuropsychological Tests; Olanzapine; Piperazines; Psychomotor Disorders; Psychotic Disorders; Quetiapine Fumarate; Schizophrenia; Schizophrenic Psychology; Sulpiride; Thiazoles; Treatment Outcome; Young Adult	2013
Comparison of metabolic effects of ziprasidone versus olanzapine treatment in patients with first-episode schizophrenia. Psychopharmacology, 2013, Volume: 225, Issue:3 Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Body Weight; Female; Glucose; Humans; Insulin; Lipid Metabolism; Male; Middle Aged; Olanzapine; Piperazines; Schizophrenia; Thiazoles; Young Adult	2013
One-year, randomized, open trial comparing olanzapine, quetiapine, risperidone and ziprasidone effectiveness in antipsychotic-naive patients with a first-episode psychosis. Psychiatry research, 2012, Dec-30, Volume: 200, Issue:2-3 Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Female; Humans; Male; Olanzapine; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome	2012
Early prediction of clinical and functional outcome in schizophrenia. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2013, Volume: 23, Issue:8 Topics: Adult; Antipsychotic Agents; Benzodiazepines; Cognition; Cognition Disorders; Double-Blind Method; Drug Monitoring; Drug Resistance; Female; Follow-Up Studies; Humans; Male; Middle Aged; Models, Biological; Olanzapine; Patient Dropouts; Piperazines; Prognosis; Psychiatric Status Rating Scales; Schizophrenia; Thiazoles; Weight Gain	2013
Lessons learned in the conduct of a global, large simple trial of treatments indicated for schizophrenia. Contemporary clinical trials, 2013, Volume: 34, Issue:2 Topics: Antipsychotic Agents; Benzodiazepines; Cause of Death; Humans; International Cooperation; Longitudinal Studies; Lost to Follow-Up; Olanzapine; Patient Selection; Piperazines; Research Design; Schizophrenia; Thiazoles	2013
Long-term safety of ziprasidone in schizophrenic patients: an open trial. European review for medical and pharmacological sciences, 2012, Volume: 16, Issue:15 Topics: Adolescent; Adult; Antipsychotic Agents; Electrocardiography; Female; Humans; Male; Middle Aged; Piperazines; Schizophrenia; Thiazoles	2012
Long-term safety and tolerability of iloperidone: results from a 25-week, open-label extension trial. CNS spectrums, 2013, Volume: 18, Issue:1 Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Substitution; Female; Humans; India; Isoxazoles; Longitudinal Studies; Male; Middle Aged; Piperazines; Piperidines; Psychiatric Status Rating Scales; Schizophrenia; Thiazoles; Time Factors; Treatment Outcome; United States; Young Adult	2013
A 1-year, double-blind, placebo-controlled trial of ziprasidone 40, 80 and 160 mg/day in chronic schizophrenia: the Ziprasidone Extended Use in Schizophrenia (ZEUS) study. International clinical psychopharmacology, 2002, Volume: 17, Issue:5 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Chronic Disease; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Recurrence; Schizophrenia; Thiazoles; Time Factors; Treatment Outcome	2002
Ziprasidone augmentation of clozapine in 11 patients. The Journal of clinical psychiatry, 2003, Volume: 64, Issue:2 Topics: Adult; Antipsychotic Agents; Clozapine; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Piperazines; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Thiazoles; Treatment Outcome; Weight Gain	2003
Effectiveness of switching to ziprasidone for stable but symptomatic outpatients with schizophrenia. The Journal of clinical psychiatry, 2003, Volume: 64, Issue:5 Topics: Adolescent; Adult; Ambulatory Care; Antipsychotic Agents; Benzodiazepines; Cross-Over Studies; Female; Humans; Male; Middle Aged; Olanzapine; Piperazines; Pirenzepine; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Thiazoles; Treatment Outcome	2003
Randomized, controlled, double-blind, multicenter comparison of the cognitive effects of ziprasidone versus olanzapine in acutely ill inpatients with schizophrenia or schizoaffective disorder. Psychopharmacology, 2004, Volume: 172, Issue:3 Topics: Adult; Antipsychotic Agents; Benzodiazepines; Cognition; Double-Blind Method; Female; Hospitalization; Humans; Male; Memory; Middle Aged; Olanzapine; Piperazines; Psychotic Disorders; Schizophrenia; Thiazoles	2004
Improvement in indices of health status in outpatients with schizophrenia switched to ziprasidone. Journal of clinical psychopharmacology, 2003, Volume: 23, Issue:6 Topics: Adolescent; Adult; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Body Weight; Female; Health Status Indicators; Humans; Male; Middle Aged; Olanzapine; Piperazines; Prolactin; Psychotic Disorders; Risperidone; Schizophrenia; Thiazoles; Withholding Treatment	2003
Improvement in cognitive function following a switch to ziprasidone from conventional antipsychotics, olanzapine, or risperidone in outpatients with schizophrenia. Schizophrenia research, 2004, Feb-01, Volume: 66, Issue:2-3 Topics: Adolescent; Adult; Ambulatory Care; Arousal; Attention; Benzodiazepines; Cognition; Drug Administration Schedule; Drug Tolerance; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Olanzapine; Piperazines; Risperidone; Schizophrenia; Thiazoles; Verbal Behavior	2004
A PET study of dopamine D2 and serotonin 5-HT2 receptor occupancy in patients with schizophrenia treated with therapeutic doses of ziprasidone. The American journal of psychiatry, 2004, Volume: 161, Issue:5 Topics: Adult; Antipsychotic Agents; Brain; Corpus Striatum; Drug Administration Schedule; Female; Humans; Male; Piperazines; Psychotic Disorders; Pyrimidinones; Raclopride; Receptors, Dopamine D2; Receptors, Serotonin, 5-HT2; Schizophrenia; Thiazoles; Tomography, Emission-Computed	2004
Randomized, controlled, double-blind multicenter comparison of the efficacy and tolerability of ziprasidone and olanzapine in acutely ill inpatients with schizophrenia or schizoaffective disorder. The American journal of psychiatry, 2004, Volume: 161, Issue:10 Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Lorazepam; Male; Metabolic Syndrome; Middle Aged; Olanzapine; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Thiazoles; Treatment Outcome; Weight Gain	2004
Efficacy and tolerability of ziprasidone versus risperidone in patients with acute exacerbation of schizophrenia or schizoaffective disorder: an 8-week, double-blind, multicenter trial. The Journal of clinical psychiatry, 2004, Volume: 65, Issue:12 Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Double-Blind Method; Female; Follow-Up Studies; Humans; Hyperprolactinemia; Male; Patient Dropouts; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Risperidone; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Sexual Dysfunctions, Psychological; Sleep Initiation and Maintenance Disorders; Thiazoles; Treatment Outcome	2004
Ziprasidone and haloperidol in the treatment of acute exacerbation of schizophrenia and schizoaffective disorder: comparison of intramuscular and oral formulations in a 6-week, randomized, blinded-assessment study. Psychopharmacology, 2005, Volume: 178, Issue:4 Topics: Acute Disease; Administration, Oral; Adult; Affective Disorders, Psychotic; Brief Psychiatric Rating Scale; Demography; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Haloperidol; Humans; Injections, Intramuscular; Male; Manifest Anxiety Scale; Piperazines; Schizophrenia; Severity of Illness Index; Thiazoles; Time Factors; Treatment Outcome; Withholding Treatment	2005
Cerebral cortical gray expansion associated with two second-generation antipsychotics. Biological psychiatry, 2005, Jul-01, Volume: 58, Issue:1 Topics: Adult; Antipsychotic Agents; Atrophy; Cerebral Cortex; Cognition Disorders; Female; Follow-Up Studies; Haloperidol; Humans; Magnetic Resonance Imaging; Male; Nerve Growth Factors; Piperazines; Psychiatric Status Rating Scales; Quality of Life; Risperidone; Schizophrenia; Schizophrenic Psychology; Thiazoles; Treatment Outcome	2005
Six-month, blinded, multicenter continuation study of ziprasidone versus olanzapine in schizophrenia. The American journal of psychiatry, 2005, Volume: 162, Issue:8 Topics: Ambulatory Care; Antipsychotic Agents; Benzodiazepines; Brief Psychiatric Rating Scale; Double-Blind Method; Drug Administration Schedule; Follow-Up Studies; Humans; Obesity; Olanzapine; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Thiazoles; Treatment Outcome; Weight Gain	2005
Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. The New England journal of medicine, 2005, Sep-22, Volume: 353, Issue:12 Topics: Adult; Antipsychotic Agents; Benzodiazepines; Chronic Disease; Dibenzothiazepines; Double-Blind Method; Female; Humans; Lipids; Male; Olanzapine; Patient Compliance; Perphenazine; Piperazines; Proportional Hazards Models; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome; Weight Gain	2005
Olanzapine versus ziprasidone: results of a 28-week double-blind study in patients with schizophrenia. The American journal of psychiatry, 2005, Volume: 162, Issue:10 Topics: Adult; Age of Onset; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Blood Glucose; Double-Blind Method; Drug Administration Schedule; Fasting; Female; Humans; Lipids; Male; Olanzapine; Piperazines; Psychiatric Status Rating Scales; Quality of Life; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Thiazoles; Treatment Outcome	2005
Efficacy and tolerability of ziprasidone in patients with treatment-resistant schizophrenia. International clinical psychopharmacology, 2006, Volume: 21, Issue:1 Topics: Adult; Antipsychotic Agents; Brief Psychiatric Rating Scale; Chlorpromazine; Double-Blind Method; Drug Resistance; Female; Haloperidol; Humans; Male; Piperazines; Prolactin; Schizophrenia; Thiazoles; Time Factors	2006
Neuropsychological normalization with long-term atypical antipsychotic treatment: results of a six-month randomized, double-blind comparison of ziprasidone vs. olanzapine. The Journal of neuropsychiatry and clinical neurosciences, 2006,Winter, Volume: 18, Issue:1 Topics: Adult; Antipsychotic Agents; Benzodiazepines; Cognition Disorders; Double-Blind Method; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Olanzapine; Patient Admission; Piperazines; Psychometrics; Psychotic Disorders; Schizophrenia; Thiazoles	2006
Ziprasidone and amisulpride effectively treat negative symptoms of schizophrenia: results of a 12-week, double-blind study. International clinical psychopharmacology, 2006, Volume: 21, Issue:3 Topics: Adult; Adverse Drug Reaction Reporting Systems; Amisulpride; Antipsychotic Agents; Behavioral Symptoms; Double-Blind Method; Female; Hospitalization; Humans; Ketones; Male; Middle Aged; Movement Disorders; Piperazines; Psychiatric Status Rating Scales; Schizophrenia; Sulpiride; Thiazoles; Time Factors; Treatment Outcome; Weight Gain; Weight Loss	2006
Effect of initial ziprasidone dose on length of therapy in schizophrenia. Schizophrenia research, 2006, Volume: 83, Issue:2-3 Topics: Adult; Antipsychotic Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Piperazines; Proportional Hazards Models; Psychiatric Status Rating Scales; Retrospective Studies; Risk; Schizophrenia; Thiazoles; Time Factors; Treatment Outcome	2006
Effect of initial ziprasidone dose on treatment persistence in schizophrenia. Schizophrenia research, 2006, Volume: 83, Issue:2-3 Topics: Adult; Antipsychotic Agents; Chi-Square Distribution; Demography; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Male; Middle Aged; Piperazines; Proportional Hazards Models; Psychiatric Status Rating Scales; Retrospective Studies; Schizophrenia; Sensitivity and Specificity; Thiazoles; Treatment Outcome	2006
Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment. The American journal of psychiatry, 2006, Volume: 163, Issue:4 Topics: Adult; Agranulocytosis; Antipsychotic Agents; Benzodiazepines; Chronic Disease; Clozapine; Cross-Over Studies; Dibenzothiazepines; Drug Monitoring; Drug Resistance; Eosinophilia; Female; Follow-Up Studies; Humans; Male; Olanzapine; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Thiazoles; Treatment Outcome	2006
Effectiveness of olanzapine, quetiapine, risperidone, and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical antipsychotic. The American journal of psychiatry, 2006, Volume: 163, Issue:4 Topics: Adult; Antipsychotic Agents; Benzodiazepines; Body Weight; Chronic Disease; Cross-Over Studies; Dibenzothiazepines; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Olanzapine; Patient Dropouts; Piperazines; Proportional Hazards Models; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Survival Analysis; Thiazoles; Time Factors; Treatment Outcome	2006
A 24-week randomized study of olanzapine versus ziprasidone in the treatment of schizophrenia or schizoaffective disorder in patients with prominent depressive symptoms. Journal of clinical psychopharmacology, 2006, Volume: 26, Issue:2 Topics: Antipsychotic Agents; Benzodiazepines; Depression; Glycated Hemoglobin; Humans; Olanzapine; Patient Dropouts; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Thiazoles; Treatment Outcome; Triglycerides; United States; Weight Gain	2006
Efficacy of ziprasidone against hostility in schizophrenia: Post hoc analysis of randomized, open-label study data. The Journal of clinical psychiatry, 2006, Volume: 67, Issue:4 Topics: Administration, Oral; Adolescent; Adult; Aged; Antipsychotic Agents; Female; Haloperidol; Hospitalization; Hostility; Humans; Injections, Intramuscular; Male; Middle Aged; Piperazines; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Thiazoles; Treatment Outcome	2006
Intramuscular ziprasidone treatment of acute psychotic agitation in elderly patients with schizophrenia. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2006, Volume: 14, Issue:7 Topics: Acute Disease; Aged; Aged, 80 and over; Antipsychotic Agents; Drug Administration Schedule; Female; Humans; Injections, Intramuscular; Male; Middle Aged; Piperazines; Psychomotor Agitation; Psychotic Disorders; Schizophrenia; Thiazoles	2006
Ziprasidone-induced cognitive enhancement in schizophrenia: specificity or pseudospecificity? Schizophrenia research, 2006, Volume: 87, Issue:1-3 Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Brief Psychiatric Rating Scale; Cognition; Cognition Disorders; Female; Humans; Male; Memory; Middle Aged; Neuropsychological Tests; Piperazines; Schizophrenia; Severity of Illness Index; Thiazoles	2006
Early changes of plasma lipids during treatment with atypical antipsychotics. International clinical psychopharmacology, 2006, Volume: 21, Issue:6 Topics: Adolescent; Adult; Aged; Amisulpride; Analysis of Variance; Antipsychotic Agents; Benzodiazepines; Body Mass Index; Body Weight; Cholesterol; Clozapine; Humans; Lipids; Middle Aged; Olanzapine; Piperazines; Prospective Studies; Schizophrenia; Sulpiride; Thiazoles; Time Factors; Triglycerides	2006
The relationship between quality of life and clinical efficacy from a randomized trial comparing olanzapine and ziprasidone. The Journal of clinical psychiatry, 2006, Volume: 67, Issue:9 Topics: Antipsychotic Agents; Benzodiazepines; Double-Blind Method; Health Status; Humans; Longitudinal Studies; Olanzapine; Piperazines; Psychiatric Status Rating Scales; Quality of Life; Schizophrenia; Schizophrenic Psychology; Thiazoles; Treatment Outcome	2006
[Switching patients with schizophrenia to ziprasidone from conventional or other atypical antipsychotics]. Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology, 2006, Volume: 8, Issue:4 Topics: Adult; Aged; Antipsychotic Agents; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Thiazoles; Treatment Outcome	2006
Effects of antipsychotic medications on psychosocial functioning in patients with chronic schizophrenia: findings from the NIMH CATIE study. The American journal of psychiatry, 2007, Volume: 164, Issue:3 Topics: Adaptation, Psychological; Antipsychotic Agents; Benzodiazepines; Chronic Disease; Clozapine; Dibenzothiazepines; Follow-Up Studies; Health Status; Humans; National Institute of Mental Health (U.S.); Olanzapine; Patient Dropouts; Perphenazine; Piperazines; Quality of Life; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Social Adjustment; Thiazoles; Treatment Outcome; United States	2007
Ziprasidone outcome and tolerability: a practical clinical trial with plasma drug levels. Pharmacopsychiatry, 2007, Volume: 40, Issue:3 Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Body Weight; Chromatography, High Pressure Liquid; Electrocardiography; Female; Humans; Male; Middle Aged; Piperazines; Schizophrenia; Thiazoles	2007
Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial. Archives of general psychiatry, 2007, Volume: 64, Issue:6 Topics: Adult; Antipsychotic Agents; Benzodiazepines; Cognition Disorders; Cohort Studies; Dibenzothiazepines; Double-Blind Method; Female; Humans; Male; Neuropsychological Tests; Olanzapine; Perphenazine; Piperazines; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Thiazoles; Treatment Outcome	2007
Effectiveness, safety, and tolerability of ziprasidone for treating schizophrenia patients undergoing usual care: a 12-month, open-label, flexible-dose, naturalistic observational trial. Progress in neuro-psychopharmacology & biological psychiatry, 2007, Oct-01, Volume: 31, Issue:7 Topics: Adult; Antipsychotic Agents; Body Weight; Chronic Disease; Female; Humans; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Schizophrenia; Thiazoles	2007
Cost-effectiveness analysis of ziprasidone versus haloperidol in sequential intramuscular/oral treatment of exacerbation of schizophrenia: economic subanalysis of the ZIMO trial. Clinical drug investigation, 2007, Volume: 27, Issue:9 Topics: Administration, Oral; Adult; Antipsychotic Agents; Brief Psychiatric Rating Scale; Cost of Illness; Cost-Benefit Analysis; Drug Costs; Drug Therapy, Combination; Female; Haloperidol; Hospital Costs; Humans; Injections, Intramuscular; Length of Stay; Male; Piperazines; Quality of Life; Research Design; Schizophrenia; Spain; Thiazoles; Treatment Outcome	2007
Ziprasidone in treatment-resistant schizophrenia: a 52-week, open-label continuation study. The Journal of clinical psychiatry, 2007, Volume: 68, Issue:9 Topics: Adult; Antipsychotic Agents; Brief Psychiatric Rating Scale; Chlorpromazine; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Drug Administration Schedule; Drug Resistance, Multiple; Female; Humans; Male; Piperazines; Schizophrenia; Thiazoles; Treatment Outcome	2007
Comparison of ziprasidone and aripiprazole in acutely ill patients with schizophrenia or schizoaffective disorder: a randomized, double-blind, 4-week study. International clinical psychopharmacology, 2007, Volume: 22, Issue:6 Topics: Acute Disease; Adult; Affective Disorders, Psychotic; Antipsychotic Agents; Aripiprazole; Blood Glucose; Diagnostic and Statistical Manual of Mental Disorders; Dose-Response Relationship, Drug; Double-Blind Method; Dyspepsia; Electrocardiography; Fasting; Humans; Lipids; Nausea; Piperazines; Prolactin; Quinolones; Schizophrenia; Severity of Illness Index; Thiazoles; Time Factors; Treatment Outcome; Weight Loss	2007
Clinical implications of the CATIE schizophrenia trials: day-to-day management lessons for Australasian psychiatrists. Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists, 2007, Volume: 15, Issue:6 Topics: Antipsychotic Agents; Australia; Benzodiazepines; Dibenzothiazepines; Double-Blind Method; Humans; Olanzapine; Perphenazine; Piperazines; Psychiatry; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Thiazoles; Time Factors	2007
A randomized double-blind comparison of ziprasidone vs. clozapine for cognition in patients with schizophrenia selected for resistance or intolerance to previous treatment. Schizophrenia research, 2008, Volume: 105, Issue:1-3 Topics: Adult; Antipsychotic Agents; Clozapine; Cognition Disorders; Double-Blind Method; Drug Resistance; Drug Tolerance; Female; Humans; Italy; Male; Memory Disorders; Neuropsychological Tests; Piperazines; Placebos; Schizophrenia; Schizophrenic Psychology; Thiazoles; Trail Making Test; Treatment Outcome	2008
Ziprasidone in the treatment of borderline personality disorder: a double-blind, placebo-controlled, randomized study. The Journal of clinical psychiatry, 2008, Volume: 69, Issue:4 Topics: Adolescent; Adult; Antipsychotic Agents; Bipolar Disorder; Borderline Personality Disorder; Comorbidity; Depressive Disorder, Major; Disruptive, Impulse Control, and Conduct Disorders; Double-Blind Method; Humans; Middle Aged; Neurocognitive Disorders; Piperazines; Psychoses, Substance-Induced; Schizophrenia; Substance-Related Disorders; Surveys and Questionnaires; Thiazoles	2008
The Ziprasidone Observational Study of Cardiac Outcomes (ZODIAC): design and baseline subject characteristics. The Journal of clinical psychiatry, 2008, Volume: 69, Issue:1 Topics: Adult; Antipsychotic Agents; Body Mass Index; Dyslipidemias; Female; Glycated Hemoglobin; Humans; Hypertension; Long QT Syndrome; Male; Observation; Piperazines; Prevalence; Research Design; Schizophrenia; Severity of Illness Index; Surveys and Questionnaires; Thiazoles; Triglycerides	2008
Four-week, double-blind, placebo- and ziprasidone-controlled trial of iloperidone in patients with acute exacerbations of schizophrenia. Journal of clinical psychopharmacology, 2008, Volume: 28, Issue:2 Suppl 1 Topics: Acute Disease; Adolescent; Adult; Aged; Antipsychotic Agents; Double-Blind Method; Drug Administration Schedule; Female; Humans; Isoxazoles; Male; Middle Aged; Piperazines; Piperidines; Prospective Studies; Schizophrenia; Thiazoles; Treatment Outcome	2008
Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial. Lancet (London, England), 2008, Mar-29, Volume: 371, Issue:9618 Topics: Adolescent; Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Female; Haloperidol; Humans; Linear Models; Male; Olanzapine; Patient Compliance; Piperazines; Proportional Hazards Models; Quetiapine Fumarate; Schizophrenia; Sulpiride; Thiazoles; Treatment Outcome	2008
What CATIE found: results from the schizophrenia trial. Psychiatric services (Washington, D.C.), 2008, Volume: 59, Issue:5 Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Benzodiazepines; Cost-Benefit Analysis; Dibenzothiazepines; Double-Blind Method; Drug Administration Schedule; Dyskinesia, Drug-Induced; Female; Humans; Male; Middle Aged; Olanzapine; Perphenazine; Piperazines; Psychology; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles	2008
An exploratory haloperidol-controlled dose-finding study of ziprasidone in hospitalized patients with schizophrenia or schizoaffective disorder. Journal of clinical psychopharmacology, 1998, Volume: 18, Issue:4 Topics: Adult; Antipsychotic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Haloperidol; Hospitalization; Humans; Male; Middle Aged; Neurologic Examination; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Thiazoles; Treatment Outcome	1998
Ziprasidone 40 and 120 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: a 4-week placebo-controlled trial. Psychopharmacology, 1998, Volume: 140, Issue:2 Topics: Acute Disease; Adolescent; Adult; Aged; Antipsychotic Agents; Double-Blind Method; Electrocardiography; Female; Humans; Male; Middle Aged; Piperazines; Psychotic Disorders; Schizophrenia; Thiazoles	1998
Ziprasidone 80 mg/day and 160 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: a 6-week placebo-controlled trial. Ziprasidone Study Group. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 1999, Volume: 20, Issue:5 Topics: Acute Disease; Adolescent; Adult; Aged; Antipsychotic Agents; Double-Blind Method; Female; Humans; Male; Middle Aged; Piperazines; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Thiazoles	1999
Intramuscular ziprasidone, 2 mg versus 10 mg, in the short-term management of agitated psychotic patients. The Journal of clinical psychiatry, 2001, Volume: 62, Issue:1 Topics: Antipsychotic Agents; Area Under Curve; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Injections, Intramuscular; Male; Piperazines; Psychiatric Status Rating Scales; Psychomotor Agitation; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Thiazoles; Treatment Outcome	2001
The apparent effects of ziprasidone on plasma lipids and glucose. The Journal of clinical psychiatry, 2001, Volume: 62, Issue:5 Topics: Adult; Analysis of Variance; Antipsychotic Agents; Blood Glucose; Body Mass Index; Body Weight; Cholesterol; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Lipids; Male; Outcome Assessment, Health Care; Piperazines; Psychotic Disorders; Schizophrenia; Thiazoles; Triglycerides	2001
A 28-week comparison of ziprasidone and haloperidol in outpatients with stable schizophrenia. The Journal of clinical psychiatry, 2002, Volume: 63, Issue:6 Topics: Adolescent; Adult; Antipsychotic Agents; Female; Haloperidol; Humans; Male; Middle Aged; Nausea; Piperazines; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Sleep Initiation and Maintenance Disorders; Thiazoles; Treatment Outcome; Vomiting	2002

Other Studies

138 other study(ies) available for ziprasidone and Dementia Praecox

Article	Year
Asenapine: a novel psychopharmacologic agent with a unique human receptor signature. Journal of psychopharmacology (Oxford, England), 2009, Volume: 23, Issue:1 Topics: Benzodiazepines; Bipolar Disorder; Clinical Trials as Topic; Cloning, Molecular; Clozapine; Dibenzocycloheptenes; Heterocyclic Compounds, 4 or More Rings; Histamine Release; Humans; Inhibitory Concentration 50; Molecular Structure; Olanzapine; Psychotropic Drugs; Radioligand Assay; Receptors, Adrenergic; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Muscarinic; Receptors, Serotonin; Schizophrenia; Substrate Specificity	2009
Synthesis and evaluation of 1-(quinoliloxypropyl)-4-aryl piperazines for atypical antipsychotic effect. Bioorganic & medicinal chemistry letters, 2009, Jun-01, Volume: 19, Issue:11 Topics: Animals; Antipsychotic Agents; Mice; Oxyquinoline; Schizophrenia; Stereotyped Behavior	2009
The safety and efficacy of sequential intramuscular/oral ziprasidone treatment of acute episode in patients with schizophrenia: a multicenter, open-labeled study. BMC psychiatry, 2023, 03-15, Volume: 23, Issue:1 Topics: Antipsychotic Agents; Humans; Injections, Intramuscular; Piperazines; Psychiatric Status Rating Scales; Schizophrenia; Thiazoles; Treatment Outcome	2023
Atypical antipsychotics attenuate MK801-induced social withdrawal and hyperlocomotion in the RHA rat model of schizophrenia-relevant features. Psychopharmacology, 2023, Volume: 240, Issue:9 Topics: Animals; Antipsychotic Agents; Aripiprazole; Clozapine; Dizocilpine Maleate; Male; Rats; Schizophrenia; Social Isolation	2023
Health Care Cost in Patients With Schizophrenia Treated With Brexpiprazole Versus Other Oral Atypical Antipsychotic Therapy. Clinical therapeutics, 2020, Volume: 42, Issue:1 Topics: Administration, Oral; Adult; Antipsychotic Agents; Aripiprazole; Female; Health Care Costs; Hospitalization; Humans; Lurasidone Hydrochloride; Male; Medicaid; Medicare; Middle Aged; Olanzapine; Paliperidone Palmitate; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Thiazoles; Thiophenes; United States	2020
When Green Becomes Mean: Green Tea Extract Reduces Ziprasidone's Effect and Causes Psychosis. The primary care companion for CNS disorders, 2020, 01-23, Volume: 22, Issue:1 Topics: Antipsychotic Agents; Food-Drug Interactions; Humans; Male; Piperazines; Psychoses, Substance-Induced; Schizophrenia; Tea; Thiazoles; Young Adult	2020
[Electroconvulsive Therapy - A beneficial and well tolerated therapy in children and adolescents with schizophrenia]. Fortschritte der Neurologie-Psychiatrie, 2020, Volume: 88, Issue:8 Topics: Adolescent; Catatonia; Child; Clozapine; Combined Modality Therapy; Electroconvulsive Therapy; Humans; Piperazines; Schizophrenia; Thiazoles; Treatment Outcome	2020
Parenteral Sustained Release Lipid Phase-Transition System of Ziprasidone: Fabrication and Evaluation for Schizophrenia Therapy. Drug design, development and therapy, 2020, Volume: 14 Topics: Animals; Antipsychotic Agents; Delayed-Action Preparations; Lipids; Male; Piperazines; Rats; Rats, Sprague-Dawley; Schizophrenia; Thiazoles	2020
Identification and Quantification of Antipsychotics in Blood Samples by LC-MS-MS: Case Reports and Data from Three Years of Routine Analysis. Journal of analytical toxicology, 2020, Dec-12, Volume: 44, Issue:8 Topics: Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Chromatography, Liquid; Clozapine; Dibenzothiazepines; Female; Forensic Toxicology; Humans; Male; Olanzapine; Paliperidone Palmitate; Piperazines; Quetiapine Fumarate; Retrospective Studies; Risperidone; Schizophrenia; Substance Abuse Detection; Suicide; Sulpiride; Tandem Mass Spectrometry; Thiazoles	2020
Effects of haloperidol, olanzapine, ziprasidone, and PHA-543613 on spatial learning and memory in the Morris water maze test in naïve and MK-801-treated mice. Brain and behavior, 2017, Volume: 7, Issue:8 Topics: Animals; Antipsychotic Agents; Benzodiazepines; Bridged Bicyclo Compounds, Heterocyclic; Disease Models, Animal; Haloperidol; Male; Maze Learning; Memory; Mice; Mice, Inbred C57BL; Olanzapine; Piperazines; Quinuclidines; Schizophrenia; Spatial Learning; Thiazoles; Treatment Outcome	2017
Comparison of outcomes for African Americans, Hispanics, and Non-Hispanic Whites in the CATIE study. Psychiatric services (Washington, D.C.), 2013, Volume: 64, Issue:6 Topics: Adult; Antipsychotic Agents; Black or African American; Clinical Trials as Topic; Female; Hispanic or Latino; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Patient Dropouts; Perphenazine; Piperazines; Schizophrenia; Thiazoles; United States; White People; Young Adult	2013
Immediate intervention: life-long success. Schizophrenia bulletin, 2014, Volume: 40, Issue:1 Topics: Adult; Antipsychotic Agents; Cognitive Behavioral Therapy; Female; Humans; Piperazines; Schizophrenia; Thiazoles; Treatment Outcome; Trifluoperazine	2014
Short-term remission in schizophrenia as a combination of several outcome measures. Psychiatry research, 2013, Oct-30, Volume: 209, Issue:3 Topics: Adolescent; Adult; Antipsychotic Agents; Body Mass Index; Cognition Disorders; Female; Humans; Logistic Models; Male; Middle Aged; Outcome Assessment, Health Care; Piperazines; Psychiatric Status Rating Scales; Recurrence; Schizophrenia; Thiazoles; Treatment Outcome; Young Adult	2013
Switching to ziprasidone in the clinical practice setting: an open-label study. International journal of psychiatry in medicine, 2013, Volume: 45, Issue:2 Topics: Adult; Antipsychotic Agents; Body Weight; Brief Psychiatric Rating Scale; Drug Substitution; Female; Follow-Up Studies; Humans; Male; Middle Aged; Piperazines; Psychometrics; Psychotic Disorders; Quality of Life; Schizophrenia; Schizophrenic Psychology; Thiazoles; Treatment Outcome	2013
From the editor-in-chief's desk. Journal of child and adolescent psychopharmacology, 2013, Volume: 23, Issue:8 Topics: Antipsychotic Agents; Humans; Piperazines; Schizophrenia; Thiazoles	2013
Effects of antipsychotic drugs on insight in schizophrenia. Psychiatry research, 2014, Aug-15, Volume: 218, Issue:1-2 Topics: Adult; Antipsychotic Agents; Aripiprazole; Awareness; Benzodiazepines; Female; Haloperidol; Humans; Male; Middle Aged; Olanzapine; Piperazines; Psychotic Disorders; Quinolones; Schizophrenia; Schizophrenic Psychology; Thiazoles	2014
Comparison of health services use associated with ziprasidone and olanzapine among schizophrenia and bipolar disorder patients in the USA. Clinical drug investigation, 2014, Volume: 34, Issue:7 Topics: Adult; Ambulatory Care; Benzodiazepines; Bipolar Disorder; Emergency Service, Hospital; Female; Health Care Costs; Health Services; Humans; Male; Middle Aged; Olanzapine; Piperazines; Schizophrenia; Thiazoles; United States	2014
Cost-effectiveness of second-generation antipsychotics for the treatment of schizophrenia. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 2014, Volume: 17, Issue:4 Topics: Adult; Antipsychotic Agents; Benzodiazepines; Clozapine; Cost-Benefit Analysis; Dibenzothiazepines; Drug Therapy, Combination; Female; Humans; Male; Markov Chains; Olanzapine; Piperazines; Quality-Adjusted Life Years; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles	2014
Dried blood spot testing: a novel approach for the therapeutic drug monitoring of ziprasidone-treated patients. Bioanalysis, 2014, Volume: 6, Issue:11 Topics: Blood Specimen Collection; Chromatography, Liquid; Dried Blood Spot Testing; Drug Monitoring; Humans; Piperazines; Schizophrenia; Tandem Mass Spectrometry; Thiazoles	2014
Treatment with Ziprasidone for schizophrenia patients with OCD. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2014, Volume: 24, Issue:9 Topics: Adult; Analysis of Variance; Antipsychotic Agents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Schizophrenia; Thiazoles; Treatment Outcome; Young Adult	2014
Update on putative novel antipsychotics. Clinical schizophrenia & related psychoses, 2014, Volume: 8, Issue:2 Topics: Antipsychotic Agents; Brain Injuries; Clozapine; Cognition Disorders; Drug Therapy, Combination; Employment, Supported; Humans; Piperazines; Schizophrenia; Thiazoles	2014
Understanding responder neurobiology in schizophrenia using a quantitative systems pharmacology model: application to iloperidone. Journal of psychopharmacology (Oxford, England), 2015, Volume: 29, Issue:4 Topics: Antipsychotic Agents; Computer Simulation; Genotype; Humans; Isoxazoles; Models, Biological; Molecular Targeted Therapy; Neurobiology; Pharmacogenetics; Piperazines; Piperidines; Schizophrenia; Thiazoles	2015
Transient agranulocytosis associated with ziprasidone in a 45-year-old man on hemodialysis. Journal of clinical psychopharmacology, 2015, Volume: 35, Issue:3 Topics: Agranulocytosis; Antipsychotic Agents; Humans; Kidney Failure, Chronic; Male; Middle Aged; Piperazines; Renal Dialysis; Schizophrenia; Thiazoles	2015
Did FDA Decisionmaking Affect Anti-Psychotic Drug Prescribing in Children?: A Time-Trend Analysis. PloS one, 2016, Volume: 11, Issue:3 Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Child; Decision Making; Drug Approval; Drug Prescriptions; Female; Humans; Male; Middle Aged; Olanzapine; Pediatrics; Piperazines; Quetiapine Fumarate; Schizophrenia; Thiazoles; United States; United States Food and Drug Administration	2016
Development of a Web-Based Clinical Decision Support System for Drug Prescription: Non-Interventional Naturalistic Description of the Antipsychotic Prescription Patterns in 4345 Outpatients and Future Applications. PloS one, 2016, Volume: 11, Issue:10 Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Community Mental Health Centers; Decision Support Systems, Clinical; Drug Prescriptions; Female; Humans; Inappropriate Prescribing; Internet; Male; Middle Aged; Outpatients; Paliperidone Palmitate; Piperazines; Schizophrenia; Thiazoles; Young Adult	2016
Real-world adherence assessment of lurasidone and other oral atypical antipsychotics among patients with schizophrenia: an administrative claims analysis. Current medical research and opinion, 2017, Volume: 33, Issue:5 Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Female; Humans; Insurance Claim Review; Lurasidone Hydrochloride; Male; Medicaid; Medication Adherence; Middle Aged; Olanzapine; Piperazines; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles; United States	2017
A neuroimaging study of emotion-cognition interaction in schizophrenia: the effect of ziprasidone treatment. Psychopharmacology, 2017, Volume: 234, Issue:7 Topics: Adolescent; Adult; Antipsychotic Agents; Brain Mapping; Cognition; Emotions; Female; Gray Matter; Humans; Magnetic Resonance Imaging; Male; Neuroimaging; Piperazines; Prefrontal Cortex; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Thiazoles; White Matter; Young Adult	2017
Assessment of clinical and metabolic status, and subjective well-being, in schizophrenic patients switched from typical and atypical antipsychotics to ziprasidone. International clinical psychopharmacology, 2008, Volume: 23, Issue:4 Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Female; Haloperidol; Humans; Male; Middle Aged; Olanzapine; Patient Compliance; Piperazines; Quality of Life; Risperidone; Schizophrenia; Schizophrenic Psychology; Thiazoles	2008
Clinical experiences and clinical trials. CNS spectrums, 2008, Volume: 13, Issue:6 Topics: Antipsychotic Agents; Benzodiazepines; Chronic Disease; Dyskinesia, Drug-Induced; Humans; Olanzapine; Perphenazine; Piperazines; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Schizophrenic Psychology; Thiazoles; Treatment Outcome	2008
Repeated acute dystonia following administration of amisulpride and ziprasidone in a patient with iron deficiency. Progress in neuro-psychopharmacology & biological psychiatry, 2008, Aug-01, Volume: 32, Issue:6 Topics: Adolescent; Amisulpride; Anemia, Iron-Deficiency; Antipsychotic Agents; Dibenzothiazepines; Dystonia; Female; Hemoglobins; Humans; Piperazines; Quetiapine Fumarate; Schizophrenia; Sulpiride; Thiazoles	2008
Haloperidol (but not ziprasidone) withdrawal potentiates sensitization to the hyperlocomotor effect of cocaine in mice. Brain research bulletin, 2008, Sep-30, Volume: 77, Issue:2-3 Topics: Animals; Antipsychotic Agents; Behavior, Animal; Cocaine; Cocaine-Related Disorders; Haloperidol; Humans; Male; Mice; Motor Activity; Piperazines; Schizophrenia; Substance Withdrawal Syndrome; Thiazoles	2008
Ziprasidone-associated mania in Korean schizophrenic patient. Journal of clinical psychopharmacology, 2008, Volume: 28, Issue:6 Topics: Adult; Antipsychotic Agents; Asian People; Bipolar Disorder; Humans; Korea; Male; Piperazines; Schizophrenia; Schizophrenic Psychology; Thiazoles	2008
Weight effects associated with antipsychotics: a comprehensive database analysis. Schizophrenia research, 2009, Volume: 110, Issue:1-3 Topics: Antipsychotic Agents; Databases, Bibliographic; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Piperazines; Randomized Controlled Trials as Topic; Schizophrenia; Thiazoles; Time Factors; Weight Gain	2009
Maintenance of response with atypical antipsychotics in the treatment of schizophrenia: a post-hoc analysis of 5 double-blind, randomized clinical trials. BMC psychiatry, 2009, Mar-31, Volume: 9 Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Dibenzothiazepines; Female; Humans; Male; Middle Aged; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Thiazoles; Time Factors; Treatment Outcome	2009
Targeting cognition in schizophrenia research: from etiology to treatment. The American journal of psychiatry, 2009, Volume: 166, Issue:6 Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Cognition; Cognition Disorders; Dibenzothiazepines; Drug Administration Schedule; Haloperidol; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Reaction Time; Schizophrenia; Sulpiride; Thiazoles	2009
P wave and QT changes among inpatients with schizophrenia after parenteral ziprasidone administration. Pharmacological research, 2009, Volume: 60, Issue:5 Topics: Adult; Antipsychotic Agents; Atrial Fibrillation; Electrocardiography; Female; Humans; Male; Middle Aged; Piperazines; Schizophrenia; Thiazoles	2009
How dosing of ziprasidone in a state hospital system differs from product labeling. The Journal of clinical psychiatry, 2009, Volume: 70, Issue:7 Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Dibenzothiazepines; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Utilization; Female; Hospitalization; Hospitals, Psychiatric; Hospitals, State; Humans; Male; Piperazines; Prescription Drugs; Product Labeling; Psychotic Disorders; Quetiapine Fumarate; Schizophrenia; Thiazoles; Treatment Outcome	2009
FDA panel OKs 3 antipsychotic drugs for pediatric use, cautions against overuse. JAMA, 2009, Aug-26, Volume: 302, Issue:8 Topics: Adolescent; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Child; Dibenzothiazepines; Drug Approval; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Schizophrenia; Thiazoles; United States; United States Food and Drug Administration	2009
Ziprasidone-related oculogyric crisis in an adult. Clinical neurology and neurosurgery, 2009, Volume: 111, Issue:10 Topics: Adult; Antipsychotic Agents; Clonazepam; Dyskinesia, Drug-Induced; Electroencephalography; Female; GABA Modulators; Humans; Ocular Motility Disorders; Oculomotor Muscles; Piperazines; Schizophrenia; Thiazoles	2009
Pregnancy and atypical antipsychotics. Psychiatria Danubina, 2009, Volume: 21, Issue:3 Topics: Adult; Antipsychotic Agents; Chronic Disease; Drug Therapy, Combination; Female; Fluphenazine; Humans; Infant, Newborn; Piperazines; Pregnancy; Pregnancy Complications; Recurrence; Schizophrenia; Thiazoles	2009
Impact of real-world ziprasidone dosing on treatment discontinuation rates in patients with schizophrenia or bipolar disorder. Schizophrenia research, 2009, Volume: 115, Issue:2-3 Topics: Adult; Analysis of Variance; Antipsychotic Agents; Bipolar Disorder; Clinical Trials as Topic; Databases, Factual; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; International Classification of Diseases; Male; Middle Aged; Piperazines; Probability; Propensity Score; Proportional Hazards Models; Psychiatric Status Rating Scales; Retrospective Studies; Schizophrenia; Thiazoles; Time Factors; Treatment Outcome	2009
Ziprasidone as a possible cause of cleft palate in a newborn. Psychiatria Danubina, 2010, Volume: 22, Issue:1 Topics: Adult; Antipsychotic Agents; Cleft Palate; Dose-Response Relationship, Drug; Female; Humans; Infant, Newborn; Piperazines; Pregnancy; Pregnancy Complications; Risk Factors; Schizophrenia; Thiazoles; Ultrasonography, Prenatal	2010
Comparison of short-acting intramuscular antipsychotic medication: impact on length of stay and cost. American journal of therapeutics, 2011, Volume: 18, Issue:4 Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Cohort Studies; Drug Costs; Female; Haloperidol; Humans; Injections, Intramuscular; Length of Stay; Male; Middle Aged; Olanzapine; Piperazines; Psychomotor Agitation; Quinolones; Retrospective Studies; Schizophrenia; Thiazoles	2011
Increased striatal dopamine transporter levels, as indicated by a DAT scan, induced by ziprasidone in association to improvement of tardive dyskinesia--a case report. Progress in neuro-psychopharmacology & biological psychiatry, 2010, Aug-16, Volume: 34, Issue:6 Topics: Antipsychotic Agents; Corpus Striatum; Dopamine Plasma Membrane Transport Proteins; Dyskinesia, Drug-Induced; Humans; Male; Middle Aged; Piperazines; Schizophrenia; Thiazoles; Treatment Outcome	2010
How sequential studies inform drug development: evaluating the effect of food intake on optimal bioavailability of ziprasidone. Journal of psychiatric practice, 2010, Volume: 16, Issue:2 Topics: Administration, Oral; Adolescent; Adult; Antipsychotic Agents; Biological Availability; Biomedical Research; Bipolar Disorder; Dietary Fats; Dose-Response Relationship, Drug; Drug Evaluation; Drug Monitoring; Drugs, Investigational; Energy Intake; Fasting; Female; Food-Drug Interactions; Humans; Intestinal Absorption; Male; Middle Aged; Piperazines; Postprandial Period; Psychotic Disorders; Schizophrenia; Thiazoles; Treatment Outcome; Young Adult	2010
Protracted, dose-dependent weight loss after addition of ziprasidone to a stable regimen of clozapine. Human psychopharmacology, 2010, Volume: 25, Issue:5 Topics: Adult; Antipsychotic Agents; Clozapine; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Female; Humans; Piperazines; Schizophrenia; Thiazoles; Time Factors; Weight Loss	2010
Measurement of the serotonin 1A receptor availability in patients with schizophrenia during treatment with the antipsychotic medication ziprasidone. Journal of psychopharmacology (Oxford, England), 2011, Volume: 25, Issue:6 Topics: Adult; Antipsychotic Agents; Brain; Carbon Radioisotopes; Female; Humans; Magnetic Resonance Imaging; Male; Piperazines; Positron-Emission Tomography; Psychiatric Status Rating Scales; Pyridines; Radioligand Assay; Receptor, Serotonin, 5-HT1A; Schizophrenia; Serotonin Antagonists; Thiazoles	2011
Effects of risperidone, quetiapine and ziprasidone on ethanol withdrawal syndrome in rats. Progress in neuro-psychopharmacology & biological psychiatry, 2011, Mar-30, Volume: 35, Issue:2 Topics: Alcoholism; Animals; Antipsychotic Agents; Behavior, Animal; Body Weight; Central Nervous System Depressants; Comorbidity; Dibenzothiazepines; Ethanol; Humans; Hyperkinesis; Male; Motor Activity; Piperazines; Psychomotor Agitation; Quetiapine Fumarate; Rats; Rats, Wistar; Risperidone; Schizophrenia; Substance Withdrawal Syndrome; Thiazoles; Time Factors	2011
Clinical Global Impression of Improvement (CGI-I) as a valid proxy measure for remission in schizophrenia: analyses of ziprasidone clinical study data. Schizophrenia research, 2011, Volume: 126, Issue:1-3 Topics: Antipsychotic Agents; Follow-Up Studies; Humans; Outcome Assessment, Health Care; Piperazines; Predictive Value of Tests; Proxy; Psychiatric Status Rating Scales; ROC Curve; Schizophrenia; Schizophrenic Psychology; Secondary Prevention; Thiazoles	2011
Switching among antipsychotics in everyday clinical practice: focus on ziprasidone. Postgraduate medicine, 2011, Volume: 123, Issue:1 Topics: Antipsychotic Agents; Drug Substitution; Humans; Patient Education as Topic; Piperazines; Schizophrenia; Thiazoles	2011
What can large simple trials do for psychiatry? The American journal of psychiatry, 2011, Volume: 168, Issue:2 Topics: Adverse Drug Reaction Reporting Systems; Antipsychotic Agents; Death, Sudden, Cardiac; Humans; Long QT Syndrome; Multicenter Studies as Topic; Piperazines; Product Surveillance, Postmarketing; Randomized Controlled Trials as Topic; Risk Factors; Schizophrenia; Thiazoles	2011
Comparative effectiveness of second-generation antipsychotic medications in early-onset schizophrenia. Schizophrenia bulletin, 2012, Volume: 38, Issue:4 Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Child; Dibenzothiazepines; Female; Hospitalization; Hospitals, Psychiatric; Humans; Male; Medication Adherence; Olanzapine; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome	2012
Use of ziprasidone in patients with schizophrenia in four European countries. European psychiatry : the journal of the Association of European Psychiatrists, 2011, Volume: 26, Issue:1 Suppl 1 Topics: Adult; Antipsychotic Agents; Cross-Sectional Studies; Europe; Female; Health Care Surveys; Humans; Male; Piperazines; Retrospective Studies; Schizophrenia; Thiazoles	2011
Antipsychotic treatment--side-effect and/or metabolic syndrome. Psychiatria Danubina, 2011, Volume: 23, Issue:1 Topics: Adult; Antipsychotic Agents; Benzodiazepines; Combined Modality Therapy; Drug Substitution; Female; Humans; Metabolic Syndrome; Olanzapine; Piperazines; Psychotherapy; Schizophrenia; Schizophrenic Psychology; Social Adjustment; Thiazoles; Weight Gain	2011
Assessments of suicidality in double-blind, placebo-controlled trials of ziprasidone. The Journal of clinical psychiatry, 2011, Volume: 72, Issue:3 Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Child; Confidence Intervals; Humans; Odds Ratio; Piperazines; Randomized Controlled Trials as Topic; Risk; Schizophrenia; Suicidal Ideation; Suicide; Suicide, Attempted; Thiazoles	2011
Question regarding ziprasidone and QTc interval prolongation in the ZODIAC study. The American journal of psychiatry, 2011, Volume: 168, Issue:6 Topics: Adult; Antipsychotic Agents; Female; Humans; Long QT Syndrome; Male; Piperazines; Schizophrenia; Thiazoles; Treatment Outcome	2011
Outcome assessment of an antipsychotic drug algorithm: effects of the Mississippi State Hospital algorithm project. Psychiatric services (Washington, D.C.), 2011, Volume: 62, Issue:8 Topics: Adult; Algorithms; Antipsychotic Agents; Female; Hospitals, State; Humans; Male; Medication Adherence; Mississippi; Piperazines; Psychiatric Status Rating Scales; Quality of Health Care; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome	2011
Pisa syndrome and laryngeal dystonia induced by novel antipsychotics. The Israel journal of psychiatry and related sciences, 2011, Volume: 48, Issue:3 Topics: Adult; Antipsychotic Agents; Dystonia; Humans; Imidazoles; Indoles; Laryngeal Diseases; Male; Middle Aged; Piperazines; Risperidone; Schizophrenia; Syndrome; Thiazoles	2011
Onset of action of atypical and typical antipsychotics in the treatment of adolescent schizophrenic psychoses. Neuro endocrinology letters, 2011, Volume: 32, Issue:5 Topics: Adolescent; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Female; Haloperidol; Humans; Male; Medical Records; Olanzapine; Perphenazine; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Sulpiride; Thiazoles; Time Factors; Treatment Outcome	2011
Ziprasidone's effect on metabolic markers in patients with diabetes and chronic schizophrenia. Clinical schizophrenia & related psychoses, 2012, Volume: 5, Issue:4 Topics: Analysis of Variance; Antipsychotic Agents; Biomarkers; Blood Glucose; Body Mass Index; Body Weight; Chronic Disease; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Humans; Insulin; Lipids; Male; Metabolic Syndrome; Middle Aged; Piperazines; Polypharmacy; Prospective Studies; Psychiatric Status Rating Scales; Schizophrenia; Thiazoles; Treatment Outcome	2012
The impact of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) on prescribing practices: an analysis of data from a large midwestern state. The Journal of clinical psychiatry, 2012, Volume: 73, Issue:4 Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Chi-Square Distribution; Clozapine; Dibenzothiazepines; Humans; Missouri; Olanzapine; Piperazines; Practice Patterns, Physicians'; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome	2012
Updating and confirming an industry-sponsored pharmacoeconomic model: comparing two antipsychotics in the treatment of schizophrenia. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 2012, Volume: 15, Issue:1 Topics: Antipsychotic Agents; Benzodiazepines; Cost-Benefit Analysis; Decision Support Techniques; Economics, Pharmaceutical; Health Services; Humans; Models, Economic; Olanzapine; Piperazines; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Recurrence; Schizophrenia; Thiazoles	2012
Serum prolactin levels and the acute-phase efficacy in drug-naïve schizophrenia treated with ziprasidone and olanzapine (translated version). East Asian archives of psychiatry : official journal of the Hong Kong College of Psychiatrists = Dong Ya jing shen ke xue zhi : Xianggang jing shen ke yi xue yuan qi kan, 2012, Volume: 22, Issue:1 Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Drug Monitoring; Female; Humans; Interview, Psychological; Male; Olanzapine; Pharmacovigilance; Piperazines; Prolactin; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Thiazoles; Treatment Outcome	2012
Network-assisted investigation of antipsychotic drugs and their targets. Chemistry & biodiversity, 2012, Volume: 9, Issue:5 Topics: Antipsychotic Agents; Clopenthixol; Databases, Factual; Drug Interactions; Gene Regulatory Networks; Humans; Piperazines; Schizophrenia; Thiazoles; Thiothixene	2012
Inhibition of mouse brown adipocyte differentiation by second-generation antipsychotics. Experimental & molecular medicine, 2012, Sep-30, Volume: 44, Issue:9 Topics: Adipocytes, Brown; Adipogenesis; Adipokines; Animals; Antipsychotic Agents; Cell Differentiation; Cell Line; Cell Survival; Clozapine; Dibenzothiazepines; Gene Expression Regulation; Humans; Mice; Piperazines; Quetiapine Fumarate; Schizophrenia; Thiazoles; Weight Gain	2012
Medication adherence and utilization in patients with schizophrenia or bipolar disorder receiving aripiprazole, quetiapine, or ziprasidone at hospital discharge: a retrospective cohort study. BMC psychiatry, 2012, Aug-02, Volume: 12 Topics: Adult; Aged; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Databases, Factual; Dibenzothiazepines; Female; Humans; Male; Medication Adherence; Patient Discharge; Piperazines; Quetiapine Fumarate; Quinolones; Retrospective Studies; Schizophrenia; Thiazoles	2012
A case of catatonia in a 14-year-old girl with schizophrenia treated with electroconvulsive therapy. Zeitschrift fur Kinder- und Jugendpsychiatrie und Psychotherapie, 2013, Volume: 41, Issue:1 Topics: Adolescent; Amantadine; Antiparkinson Agents; Antipsychotic Agents; Benzodiazepines; Catatonia; Combined Modality Therapy; Creatine Kinase; Dibenzothiazepines; Diseases in Twins; Drug Substitution; Drug Therapy, Combination; Electroconvulsive Therapy; Female; Humans; Neurologic Examination; Olanzapine; Piperazines; Quetiapine Fumarate; Recurrence; Schizophrenia; Thiazoles	2013
Priapism associated with two atypical antipsychotic agents. Pharmacotherapy, 2002, Volume: 22, Issue:8 Topics: Adult; Antipsychotic Agents; Chronic Disease; Humans; Male; Piperazines; Priapism; Risperidone; Schizophrenia; Thiazoles	2002
The value of atypical antipsychotics in the treatment of schizophrenia. Managed care (Langhorne, Pa.), 2002, Volume: 11, Issue:7 Suppl Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Dopamine Antagonists; Drug Labeling; Humans; Olanzapine; Piperazines; Pirenzepine; Quetiapine Fumarate; Risperidone; Safety; Schizophrenia; Thiazoles; United States	2002
Prolonged erections associated with ziprasidone treatment: a case report. The Journal of clinical psychiatry, 2003, Volume: 64, Issue:1 Topics: Adult; Antipsychotic Agents; Humans; Male; Penile Erection; Piperazines; Priapism; Schizophrenia; Thiazoles	2003
Mania associated with initiation of ziprasidone. The Journal of clinical psychiatry, 2003, Volume: 64, Issue:3 Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Drug Administration Schedule; Humans; Male; Piperazines; Schizophrenia; Thiazoles	2003
[Treatment of young people with atypical antipsychotic agents]. Ugeskrift for laeger, 2003, Jun-02, Volume: 165, Issue:23 Topics: Adolescent; Antipsychotic Agents; Humans; Piperazines; Schizophrenia; Thiazoles	2003
Possible ziprasidone-induced mania. Journal of the American Academy of Child and Adolescent Psychiatry, 2003, Volume: 42, Issue:9 Topics: Adolescent; Antipsychotic Agents; Bipolar Disorder; Female; Humans; Piperazines; Schizophrenia; Thiazoles	2003
Schizophrenia, VI: Treatments. The American journal of psychiatry, 2003, Volume: 160, Issue:10 Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Olanzapine; Perphenazine; Piperazines; Pirenzepine; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome	2003
Ziprasidone-induced Pisa syndrome after clozapine treatment. The Journal of neuropsychiatry and clinical neurosciences, 2003,Fall, Volume: 15, Issue:4 Topics: Clozapine; Diagnostic and Statistical Manual of Mental Disorders; Dose-Response Relationship, Drug; Drug Interactions; Dyskinesia, Drug-Induced; Dystonia; Female; Humans; Piperazines; Schizophrenia; Serotonin Antagonists; Thiazoles	2003
Similarities and differences among antipsychotics. The Journal of clinical psychiatry, 2003, Volume: 64 Suppl 17 Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Dibenzothiazepines; Haloperidol; Humans; Olanzapine; Piperazines; Pirenzepine; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Thiazoles	2003
Introduction. Ziprasidone in schizophrenia: from acute treatment to long-term management. The Journal of clinical psychiatry, 2003, Volume: 64 Suppl 19 Topics: Acute Disease; Antipsychotic Agents; Chronic Disease; Clinical Trials as Topic; Humans; Long-Term Care; Piperazines; Schizophrenia; Schizophrenic Psychology; Serotonin Antagonists; Thiazoles	2003
Ziprasidone and cognition: the evolving story. The Journal of clinical psychiatry, 2003, Volume: 64 Suppl 19 Topics: Antipsychotic Agents; Clinical Trials as Topic; Cognition Disorders; Dose-Response Relationship, Drug; Humans; Neuropsychological Tests; Piperazines; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Serotonin Antagonists; Thiazoles; Treatment Outcome	2003
Improvement in prosocial functioning after a switch to ziprasidone treatment. CNS spectrums, 2004, Volume: 9, Issue:5 Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Female; Humans; Male; Middle Aged; Olanzapine; Piperazines; Schizophrenia; Thiazoles	2004
Combination of ziprasidone and clozapine in treatment-resistant schizophrenia. Human psychopharmacology, 2004, Volume: 19, Issue:4 Topics: Adult; Antipsychotic Agents; Clozapine; Drug Resistance; Drug Therapy, Combination; Female; Humans; Piperazines; Schizophrenia; Thiazoles; Treatment Outcome	2004
Effects of acute treatment with antidepressant drugs on sensorimotor gating deficits in rats. Psychopharmacology, 2005, Volume: 178, Issue:1 Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Antipsychotic Agents; Bupropion; Citalopram; Desipramine; Dextroamphetamine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Male; Norepinephrine; Piperazines; Rats; Rats, Wistar; Reflex, Startle; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Thiazoles	2005
Atypical antipsychotics: matching receptor profile to individual patient's clinical profile. CNS spectrums, 2004, Volume: 9, Issue:10 Suppl 1 Topics: Adult; Affect; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Child; Cognition; Dibenzothiazepines; Dose-Response Relationship, Drug; Histamine; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Receptors, Muscarinic; Receptors, Serotonin; Risperidone; Schizophrenia; Thiazoles	2004
Ziprasidone: first year experience in a hospital setting. Journal of psychiatric practice, 2004, Volume: 10, Issue:6 Topics: Adult; Antipsychotic Agents; Depressive Disorder; Electrocardiography; Female; Hospitalization; Humans; Inpatients; Length of Stay; Long QT Syndrome; Male; Middle Aged; Mood Disorders; Piperazines; Retrospective Studies; Schizophrenia; Thiazoles; Treatment Outcome	2004
Tardive dyskinesia in 2 patients treated with ziprasidone. Journal of psychiatry & neuroscience : JPN, 2004, Volume: 29, Issue:6 Topics: Adult; Antipsychotic Agents; Delusions; Dose-Response Relationship, Drug; Drug Administration Schedule; Dyskinesia, Drug-Induced; Follow-Up Studies; Hallucinations; Humans; Long-Term Care; Male; Neurologic Examination; Piperazines; Psychiatric Status Rating Scales; Recurrence; Schizophrenia; Thiazoles	2004
Comparison of the metabolic effects observed in patients treated with ziprasidone versus olanzapine. International clinical psychopharmacology, 2005, Volume: 20, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Blood Glucose; Body Weight; Cholesterol, HDL; Cholesterol, LDL; Electrocardiography; Female; Glycated Hemoglobin; Heart Rate; Humans; Hyperlipidemias; Lipids; Male; Middle Aged; Olanzapine; Piperazines; Retrospective Studies; Schizophrenia; Thiazoles; Triglycerides	2005
Automated determination of ziprasidone by HPLC with column switching and spectrophotometric detection. Therapeutic drug monitoring, 2005, Volume: 27, Issue:2 Topics: Adult; Automation; Benzodiazepines; Chromatography, High Pressure Liquid; Clozapine; Drug Administration Schedule; Drug Monitoring; Female; Humans; Male; Middle Aged; Olanzapine; Piperazines; Reproducibility of Results; Schizophrenia; Sensitivity and Specificity; Spectrophotometry; Thiazoles; Time Factors	2005
Clozapine, ziprasidone and aripiprazole but not haloperidol protect against kainic acid-induced lesion of the striatum in mice, in vivo: role of 5-HT1A receptor activation. Brain research, 2005, May-10, Volume: 1043, Issue:1-2 Topics: Aminopyridines; Animals; Antipsychotic Agents; Aripiprazole; Clozapine; Corpus Striatum; Disease Models, Animal; Excitatory Amino Acid Agonists; Haloperidol; Kainic Acid; Male; Mice; Mice, Inbred C57BL; Piperazines; Piperidines; Pyridines; Quinolones; Receptor, Serotonin, 5-HT1A; Schizophrenia; Serotonin 5-HT1 Receptor Agonists; Serotonin Antagonists; Thiazoles	2005
An African patient with ziprasidone intolerance. The Journal of clinical psychiatry, 2005, Volume: 66, Issue:6 Topics: Africa; Antipsychotic Agents; Aripiprazole; Dystonia; Ethnicity; Germany; Humans; Male; Middle Aged; Pharmacogenetics; Piperazines; Quinolones; Schizophrenia; Thiazoles; Treatment Outcome	2005
Pharmacokinetic-pharmacodynamic analysis of antipsychotics-induced extrapyramidal symptoms based on receptor occupancy theory incorporating endogenous dopamine release. Drug metabolism and pharmacokinetics, 2005, Volume: 20, Issue:3 Topics: Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Clozapine; Controlled Clinical Trials as Topic; Dibenzothiazepines; Haloperidol; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D2; Risperidone; Schizophrenia; Thiazoles	2005
Methodological concerns in a trial of ziprasidone and olanzapine. The American journal of psychiatry, 2005, Volume: 162, Issue:7 Topics: Antipsychotic Agents; Benzodiazepines; Bias; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Industry; Humans; Olanzapine; Piperazines; Product Labeling; Randomized Controlled Trials as Topic; Research Design; Research Support as Topic; Schizophrenia; Thiazoles	2005
Methodological concerns in a trial of ziprasidone and olanzapine. The American journal of psychiatry, 2005, Volume: 162, Issue:7 Topics: Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Bias; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Humans; Lorazepam; Olanzapine; Piperazines; Randomized Controlled Trials as Topic; Research Design; Schizophrenia; Schizophrenic Psychology; Thiazoles	2005
Ziprasidone-induced hypersensitivity syndrome in an aged schizophrenia patient. International journal of geriatric psychiatry, 2005, Volume: 20, Issue:8 Topics: Aged; Antipsychotic Agents; Drug Hypersensitivity; Female; Humans; Piperazines; Schizophrenia; Thiazoles; Treatment Outcome	2005
Atypical antipsychotic drugs and organization of long-term semantic memory: multidimensional scaling and cluster analyses of category fluency performance in schizophrenia. The international journal of neuropsychopharmacology, 2006, Volume: 9, Issue:6 Topics: Adult; Antipsychotic Agents; Benzodiazepines; Cluster Analysis; Female; Humans; Male; Memory; Olanzapine; Piperazines; Quality of Life; Reading; Schizophrenia; Schizophrenic Psychology; Semantics; Thiazoles	2006
Urinary hesitancy and retention caused by ziprasidone. International clinical psychopharmacology, 2006, Volume: 21, Issue:1 Topics: Adult; Antipsychotic Agents; Humans; Male; Piperazines; Schizophrenia; Thiazoles; Urinary Retention	2006
From clinical research to clinical practice: a 4-year review of ziprasidone. CNS spectrums, 2005, Volume: 10, Issue:11 Suppl 1 Topics: Antipsychotic Agents; Controlled Clinical Trials as Topic; Dopamine Antagonists; Humans; Mood Disorders; Piperazines; Psychotic Disorders; Schizophrenia; Serotonin Antagonists; Thiazoles; Treatment Outcome	2005
Patient- and facility-level factors associated with diffusion of a new antipsychotic in the VA health system. Psychiatric services (Washington, D.C.), 2006, Volume: 57, Issue:1 Topics: Aged; Algorithms; Antipsychotic Agents; Drug Approval; Drug Therapy; Drug Utilization Review; Female; Humans; International Classification of Diseases; Male; Mental Health Services; Middle Aged; Piperazines; Registries; Schizophrenia; Thiazoles; United States; United States Department of Veterans Affairs; Veterans	2006
Interpreting the results of the CATIE study. Psychiatric services (Washington, D.C.), 2006, Volume: 57, Issue:1 Topics: Antipsychotic Agents; Dibenzothiazepines; Humans; National Institute of Mental Health (U.S.); Perphenazine; Piperazines; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome; United States	2006
Interpreting the results of the CATIE study. Psychiatric services (Washington, D.C.), 2006, Volume: 57, Issue:1 Topics: Antipsychotic Agents; Dibenzothiazepines; Humans; Perphenazine; Piperazines; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome	2006
Interpreting the results of the CATIE study. Psychiatric services (Washington, D.C.), 2006, Volume: 57, Issue:1 Topics: Antipsychotic Agents; Dibenzothiazepines; Humans; Perphenazine; Piperazines; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome	2006
Antipsychotic drugs and schizophrenia. The New England journal of medicine, 2006, Jan-19, Volume: 354, Issue:3 Topics: Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Humans; Olanzapine; Patient Compliance; Perphenazine; Piperazines; Quetiapine Fumarate; Schizophrenia; Thiazoles	2006
Methodological issues in a comparative study of ziprasidone and risperidone. The Journal of clinical psychiatry, 2006, Volume: 67, Issue:1 Topics: Antipsychotic Agents; Drug Administration Schedule; Humans; Piperazines; Randomized Controlled Trials as Topic; Research Design; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome	2006
Prescribing behavior and marketing practices. Psychiatric services (Washington, D.C.), 2006, Volume: 57, Issue:3 Topics: Aged; Antipsychotic Agents; Drug Industry; Drug Therapy; Female; Humans; Male; Marketing; Mental Health Services; Middle Aged; Piperazines; Practice Patterns, Physicians'; Registries; Schizophrenia; Thiazoles; United States; United States Department of Veterans Affairs; Veterans	2006
Substance use in persons with schizophrenia: baseline prevalence and correlates from the NIMH CATIE study. The Journal of nervous and mental disease, 2006, Volume: 194, Issue:3 Topics: Antipsychotic Agents; Comorbidity; Conduct Disorder; Cross-Sectional Studies; Diagnosis, Dual (Psychiatry); Double-Blind Method; Female; Humans; Male; Multicenter Studies as Topic; Piperazines; Prevalence; Randomized Controlled Trials as Topic; Risk Factors; Schizophrenia; Schizophrenic Psychology; Sex Factors; Substance-Related Disorders; Thiazoles; Treatment Outcome; United States	2006
Cost analysis of the treatment of schizophrenia in Thailand: a simulation model comparing olanzapine, risperidone, quetiapine, ziprasidone and haloperidol. Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2005, Volume: 88, Issue:9 Topics: Antipsychotic Agents; Benzodiazepines; Computer Simulation; Cost of Illness; Cost-Benefit Analysis; Dibenzothiazepines; Drug Costs; Haloperidol; Health Care Costs; Humans; Models, Econometric; Olanzapine; Piperazines; Quetiapine Fumarate; Risperidone; Schizophrenia; Thailand; Thiazoles; Treatment Outcome	2005
Ziprasidone-associated pedal edema in the treatment of schizophrenia. Progress in neuro-psychopharmacology & biological psychiatry, 2006, Volume: 30, Issue:5 Topics: Antipsychotic Agents; Diuretics; Drug Hypersensitivity; Edema; Female; Foot Diseases; Humans; Immunoglobulin E; Middle Aged; Piperazines; Schizophrenia; Thiazoles	2006
Injectable atypical antipsychotics for agitation in borderline personality disorder. Pharmacopsychiatry, 2006, Volume: 39, Issue:3 Topics: Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Borderline Personality Disorder; Comorbidity; Emergency Services, Psychiatric; Female; Humans; Injections, Intramuscular; Male; Middle Aged; Olanzapine; Piperazines; Psychiatric Status Rating Scales; Psychomotor Agitation; Psychotic Disorders; Schizophrenia; Thiazoles; Treatment Outcome	2006
The dimensions of clinical and cognitive change in schizophrenia: evidence for independence of improvements. Psychopharmacology, 2006, Volume: 187, Issue:3 Topics: Adolescent; Adult; Antipsychotic Agents; Basal Ganglia Diseases; Cognition Disorders; Female; Humans; Male; Middle Aged; Piperazines; Schizophrenia; Schizophrenic Psychology; Thiazoles	2006
A patient using ziprasidone with polydipsia, seizure, hyponatremia and rhabdomyolysis. Progress in neuro-psychopharmacology & biological psychiatry, 2006, Dec-30, Volume: 30, Issue:8 Topics: Adult; Antipsychotic Agents; Drinking Behavior; Humans; Hyponatremia; Male; Piperazines; Rhabdomyolysis; Schizophrenia; Seizures; Thiazoles	2006
Pharmacological profile of antipsychotics at monoamine receptors: atypicality beyond 5-HT2A receptor blockade. CNS & neurological disorders drug targets, 2006, Volume: 5, Issue:4 Topics: Animals; Antipsychotic Agents; Benzodiazepines; Binding, Competitive; Biogenic Monoamines; CHO Cells; Clozapine; Cricetinae; Dibenzothiazepines; Dopamine; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Receptors, Dopamine; Receptors, Serotonin; Schizophrenia; Serotonin; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT1 Receptor Antagonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Serotonin Receptor Agonists; Synaptic Transmission; Thiazoles	2006
A model of anticholinergic activity of atypical antipsychotic medications. Schizophrenia research, 2006, Volume: 88, Issue:1-3 Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Binding Sites; Clozapine; Cognition Disorders; Dibenzothiazepines; Dose-Response Relationship, Drug; Female; Humans; Male; Neuropsychological Tests; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Receptors, Cholinergic; Risperidone; Schizophrenia; Thiazoles	2006
Probable association between ziprasidone and worsening hypertension. Pharmacotherapy, 2006, Volume: 26, Issue:9 Topics: Antipsychotic Agents; Female; Humans; Hypertension; Middle Aged; Piperazines; Schizophrenia; Thiazoles	2006
Treatment adherence among patients with schizophrenia treated with atypical and typical antipsychotics. Psychiatry research, 2006, Nov-15, Volume: 144, Issue:2-3 Topics: Adult; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Drug Administration Schedule; Drug Prescriptions; Female; Humans; International Classification of Diseases; Male; Olanzapine; Patient Compliance; Piperazines; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles; Time Factors	2006
Does antipsychotic polypharmacy increase the risk for metabolic syndrome? Schizophrenia research, 2007, Volume: 89, Issue:1-3 Topics: Adult; Age Factors; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Body Mass Index; Cholesterol, HDL; Clozapine; Cross-Sectional Studies; Dibenzothiazepines; Drug Therapy, Combination; Female; Humans; Insulin Resistance; Male; Metabolic Syndrome; Middle Aged; Piperazines; Quetiapine Fumarate; Quinolones; Risk Factors; Schizophrenia; Thiazoles; Triglycerides	2007
Determination of ziprasidone in human plasma by liquid chromatography-electrospray tandem mass spectrometry and its application to plasma level determination in schizophrenia patients. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2007, Mar-01, Volume: 847, Issue:2 Topics: Adult; Aged; Chromatography, Liquid; Female; Humans; Male; Middle Aged; Molecular Structure; Piperazines; Reproducibility of Results; Schizophrenia; Tandem Mass Spectrometry; Thiazoles	2007
High-dose ziprasidone-induced acute dystonia. Progress in neuro-psychopharmacology & biological psychiatry, 2007, Mar-30, Volume: 31, Issue:2 Topics: Adult; Antipsychotic Agents; Dose-Response Relationship, Drug; Dystonia; Female; Humans; Piperazines; Schizophrenia; Thiazoles	2007
Improvement in antipsychotic-related metabolic disturbances in patients with schizophrenia switched to ziprasidone. Progress in neuro-psychopharmacology & biological psychiatry, 2007, Mar-30, Volume: 31, Issue:2 Topics: Adult; Antipsychotic Agents; Blood Glucose; Body Weight; Cholesterol; Female; Humans; Male; Metabolic Diseases; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Retrospective Studies; Schizophrenia; Severity of Illness Index; Statistics, Nonparametric; Thiazoles; Time Factors	2007
Effectiveness, tolerability, and safety of ziprasidone in patients with schizophrenia or schizoaffective disorder: results of a multi-centre observational trial. European psychiatry : the journal of the Association of European Psychiatrists, 2007, Volume: 22, Issue:3 Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Austria; Blood Glucose; Body Weight; Brief Psychiatric Rating Scale; Dose-Response Relationship, Drug; Drug-Related Side Effects and Adverse Reactions; Female; Follow-Up Studies; Germany; Humans; Lipids; Male; Middle Aged; Patient Dropouts; Piperazines; Product Surveillance, Postmarketing; Prospective Studies; Psychotic Disorders; Quality of Life; Schizophrenia; Thiazoles; Treatment Outcome	2007
Cost-effectiveness analysis of schizophrenia relapse prevention : an economic evaluation of the ZEUS (Ziprasidone-Extended-Use-In-Schizophrenia) study in Spain. Clinical drug investigation, 2006, Volume: 26, Issue:8 Topics: Adult; Antipsychotic Agents; Chronic Disease; Cost-Benefit Analysis; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Models, Econometric; Piperazines; Program Evaluation; Recurrence; Reproducibility of Results; Schizophrenia; Spain; Thiazoles; Time Factors	2006
Neuroleptic malignant syndrome induced by ziprasidone on the second day of treatment. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2007, Volume: 8, Issue:1 Topics: Adult; Antipsychotic Agents; Biperiden; Diagnosis, Differential; Diazepam; Drug Therapy, Combination; Humans; Infusions, Intravenous; Male; Neuroleptic Malignant Syndrome; Neurologic Examination; Parkinsonian Disorders; Piperazines; Schizophrenia; Thiazoles	2007
Comments on the report of neuroleptic malignant syndrome induced by ziprasidone. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2007, Volume: 8, Issue:2 Topics: Antipsychotic Agents; Benzodiazepines; Diagnosis, Differential; Humans; Male; Neuroleptic Malignant Syndrome; Olanzapine; Patient Compliance; Patient Discharge; Piperazines; Schizophrenia; Schizophrenic Psychology; Thiazoles; Treatment Outcome	2007
The relationship between symptomatic remission and neuropsychological improvement in schizophrenia patients switched to treatment with ziprasidone. Schizophrenia research, 2007, Volume: 94, Issue:1-3 Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Cognition Disorders; Humans; Middle Aged; Neuropsychological Tests; Olanzapine; Piperazines; Remission Induction; Risperidone; Schizophrenia; Thiazoles	2007
Impairment in error monitoring predicts poor executive function in schizophrenia patients. Schizophrenia research, 2007, Volume: 94, Issue:1-3 Topics: Adult; Antipsychotic Agents; Benzodiazepines; Chronic Disease; Clozapine; Cognition Disorders; Diagnostic and Statistical Manual of Mental Disorders; Female; Humans; Male; Memory, Short-Term; Neuropsychological Tests; Olanzapine; Piperazines; Reaction Time; Risperidone; Schizophrenia; Self Efficacy; Severity of Illness Index; Thiazoles	2007
Risk of discontinuation of atypical antipsychotic agents in the treatment of schizophrenia. Schizophrenia research, 2008, Volume: 98, Issue:1-3 Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Dibenzothiazepines; Female; Follow-Up Studies; Humans; Male; Middle Aged; Patient Readmission; Piperazines; Proportional Hazards Models; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risk Factors; Risperidone; Schizophrenia; Schizophrenia, Paranoid; Schizophrenic Psychology; Sensitivity and Specificity; Substance Withdrawal Syndrome; Survival Rate; Thiazoles	2008
The effectiveness of ziprasidone in treating impaired quality of life in schizophrenia: a 12-month, open-label, flexible-dose, naturalistic observational study of patients undergoing usual care. Progress in neuro-psychopharmacology & biological psychiatry, 2007, Oct-01, Volume: 31, Issue:7 Topics: Adult; Analysis of Variance; Antipsychotic Agents; Chronic Disease; Female; Humans; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Quality of Life; Schizophrenia; Schizophrenic Psychology; Surveys and Questionnaires; Thiazoles	2007
Acute urinary retention associated with selective serotonin reuptake inhibitors and ziprasidone. Journal of clinical psychopharmacology, 2007, Volume: 27, Issue:5 Topics: Acute Disease; Antipsychotic Agents; Depressive Disorder, Major; Drug Monitoring; Electroconvulsive Therapy; Humans; Male; Middle Aged; Piperazines; Receptors, Serotonin, 5-HT2; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Serotonin Plasma Membrane Transport Proteins; Thiazoles; Urinary Catheterization; Urinary Retention	2007
Show me the evidence: using number needed to treat. Southern medical journal, 2007, Volume: 100, Issue:9 Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Confidence Intervals; Data Interpretation, Statistical; Decision Making; Evidence-Based Medicine; Humans; Likelihood Functions; Olanzapine; Piperazines; Randomized Controlled Trials as Topic; Research Design; Risk Assessment; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome	2007
Efficacy of antipsychotics to reverse phencyclidine-induced social interaction deficits in female rats--a preliminary investigation. Behavioural brain research, 2008, Mar-05, Volume: 187, Issue:2 Topics: Analysis of Variance; Animals; Antipsychotic Agents; Behavior, Animal; Clozapine; Disease Models, Animal; Drug Interactions; Excitatory Amino Acid Antagonists; Female; Haloperidol; Matched-Pair Analysis; Phencyclidine; Piperazines; Rats; Rats, Inbred Strains; Schizophrenia; Schizophrenic Psychology; Social Behavior; Social Behavior Disorders; Thiazoles	2008
A case report with ziprasidone-induced catatonic symptoms. The Journal of neuropsychiatry and clinical neurosciences, 2007,Fall, Volume: 19, Issue:4 Topics: Adult; Antipsychotic Agents; Catatonia; Humans; Male; Piperazines; Psychiatric Status Rating Scales; Schizophrenia; Thiazoles	2007
Did CATIE influence antipsychotic use? Psychiatric services (Washington, D.C.), 2008, Volume: 59, Issue:5 Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Drug Therapy; Haloperidol; Humans; Olanzapine; Perphenazine; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles	2008
The distribution of body mass index among individuals with and without schizophrenia. The Journal of clinical psychiatry, 1999, Volume: 60, Issue:4 Topics: Antipsychotic Agents; Body Mass Index; Clinical Trials as Topic; Comorbidity; Female; Health Surveys; Humans; Male; Obesity; Piperazines; Schizophrenia; Sex Factors; Thiazoles; United States; Weight Gain	1999
[Therapy of schizophrenia with high compliance. Ziprasidon increases pharmaceutical options]. Der Nervenarzt, 1999, Volume: 70, Issue:11 Suppl Z Topics: Antipsychotic Agents; Hospitalization; Humans; Piperazines; Schizophrenia; Thiazoles	1999
Quality of life and new antipsychotics in schizophrenia. Are patients better off? The International journal of social psychiatry, 1999,Winter, Volume: 45, Issue:4 Topics: Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Humans; Olanzapine; Patient Compliance; Patient Satisfaction; Piperazines; Pirenzepine; Quality of Life; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles	1999
Novel antipsychotic use in schizophrenia. The Journal of clinical psychiatry, 2000, Volume: 61, Issue:3 Topics: Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Dibenzothiepins; Drug Administration Schedule; Humans; Olanzapine; Piperazines; Pirenzepine; Practice Patterns, Physicians'; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome	2000
Ziprasidone hydrochloride approved for treatment of schizophrenia, but with major warning. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2001, May-01, Volume: 58, Issue:9 Topics: Antipsychotic Agents; Drug Labeling; Humans; Piperazines; Randomized Controlled Trials as Topic; Schizophrenia; Thiazoles	2001
Ziprasidone (Geodon) for schizophrenia. The Medical letter on drugs and therapeutics, 2001, Jun-11, Volume: 43, Issue:1106 Topics: Antipsychotic Agents; Clinical Trials as Topic; Dopamine Antagonists; Humans; Intestinal Absorption; Piperazines; Schizophrenia; Serotonin Antagonists; Thiazoles	2001
Ziprasidone approved. The Harvard mental health letter, 2001, Volume: 17, Issue:12 Topics: Antipsychotic Agents; Drug Approval; Humans; Piperazines; Schizophrenia; Thiazoles	2001
Ziprasidone hydrochloride. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2002, Jan-01, Volume: 59, Issue:1 Topics: Antipsychotic Agents; Drug Interactions; Female; Humans; Male; Piperazines; Pregnancy; Schizophrenia; Thiazoles	2002
[Exercising caution in choice of psychotropic drugs. Avoid drug-induced weight gain]. MMW Fortschritte der Medizin, 2002, May-06, Volume: Suppl 2 Topics: Antipsychotic Agents; Clinical Trials as Topic; Humans; Piperazines; Schizophrenia; Schizophrenic Psychology; Thiazoles; Treatment Outcome; Weight Gain	2002